[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @investseekers Investseekers Investseekers posts on X about $nvo, stocks, novo, $lly the most. They currently have XXXXX followers and 1337 posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::1477615559252586500/interactions)  - X Week XXXXXXX +80% - X Month XXXXXXX +7.90% - X Months XXXXXXXXX +158% - X Year XXXXXXXXX +12,778% ### Mentions: XXX [#](/creator/twitter::1477615559252586500/posts_active)  - X Week XXX +24% - X Month XXX -XXXX% - X Months XXXXX +62% - X Year XXXXX +805% ### Followers: XXXXX [#](/creator/twitter::1477615559252586500/followers)  - X Week XXXXX +3.10% - X Month XXXXX +17% - X Months XXXXX +134% - X Year XXXXX +1,296% ### CreatorRank: XXXXXXX [#](/creator/twitter::1477615559252586500/influencer_rank)  ### Social Influence [#](/creator/twitter::1477615559252586500/influence) --- **Social category influence** [stocks](/list/stocks) #3376 [finance](/list/finance) #3988 [currencies](/list/currencies) #2602 [countries](/list/countries) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXX% [technology brands](/list/technology-brands) XXXX% [travel destinations](/list/travel-destinations) XXXX% [luxury brands](/list/luxury-brands) XXXX% [celebrities](/list/celebrities) XXXX% [exchanges](/list/exchanges) XXXX% **Social topic influence** [$nvo](/topic/$nvo) #7, [stocks](/topic/stocks) #958, [novo](/topic/novo) #198, [$lly](/topic/$lly) #16, [$gmab](/topic/$gmab) #2, [acquisition](/topic/acquisition) #957, [denmark](/topic/denmark) #515, [longterm](/topic/longterm) #284, [nvo](/topic/nvo) #4, [over the](/topic/over-the) XXXX% **Top accounts mentioned or mentioned by** [@hl3133](/creator/undefined) [@gusatlantis](/creator/undefined) [@fiinvest2030](/creator/undefined) [@exclamotite69](/creator/undefined) [@tacticzh](/creator/undefined) [@1daveline](/creator/undefined) [@boriszr](/creator/undefined) [@xstryx](/creator/undefined) [@tonymacarroni91](/creator/undefined) [@damianofomo](/creator/undefined) [@marcom41184621](/creator/undefined) [@tihobrkan](/creator/undefined) [@jacobcordosa](/creator/undefined) [@theeuinvestor](/creator/undefined) [@valuez6912](/creator/undefined) [@markedsbrok](/creator/undefined) [@baselinex2024](/creator/undefined) [@dywidendowopl](/creator/undefined) [@aretardinvestor](/creator/undefined) [@teechongyen](/creator/undefined) **Top assets mentioned** [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Johnson & Johnson (JNJ)](/topic/$jnj) [Copart, Inc. (CPRT)](/topic/$cprt) [Alibaba Group (BABA)](/topic/$baba) [Pfizer, Inc. (PFE)](/topic/$pfe) [Watsco, Inc. (WSO)](/topic/$wso) [JPMorgan Chase (JPM)](/topic/$jpm) [Parex (PRX)](/topic/$prx) [PoolTogether (POOL)](/topic/$pool) [Zoetis Inc (ZTS)](/topic/$zts) [Barclays PLC (BCS)](/topic/$bcs) [PepsiCo, Inc. (PEP)](/topic/$pep) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [AstraZeneca PLC (AZN)](/topic/$azn) [Morgan Stanley (MS)](/topic/morgan-stanley) [HSBC Holdings PLC (HSBC)](/topic/$hsbc) [Deutsche Bank Aktiengesellschaft (DB)](/topic/$db) [Akropolis (AKRO)](/topic/$akro) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Synthetify (SNY)](/topic/$sny) [Otis Worldwide Corp (OTIS)](/topic/$otis) [Diageo plc (DEO)](/topic/$deo) [AbbVie Inc (ABBV)](/topic/$abbv) [Sanofi (SNY)](/topic/sanofi) ### Top Social Posts [#](/creator/twitter::1477615559252586500/posts) --- Top posts by engagements in the last XX hours "@ftr_investors Revenue not below 2025 Haha $ASML really feels like the semiconductor version of $NVO absolute market leader but management is way too modest when presenting results/growth. Guess its just our European way of doing things 😄" [X Link](https://x.com/investseekers/status/1978349594623750388) [@investseekers](/creator/x/investseekers) 2025-10-15T06:37Z 4087 followers, XXX engagements "Spanish drugmaker Rovi will start producing medicines for $NVO from 2026 according to elEconomista. Rovi will manufacture pre-filled syringes likely for Novos blockbuster Ozempic and Wegovy at its Madrid facility under a five-year contract worth an estimated 82184 million annually starting in 2027. #stocks #investingtips" [X Link](https://x.com/investseekers/status/1977720148824936731) [@investseekers](/creator/x/investseekers) 2025-10-13T12:56Z 4105 followers, 2773 engagements "A rough day on the Danish stock market. The C25 index fell XXX% on Tuesday pressured by declines in $NVO and green #stocks . Novo Nordisk dropped XXX% marking its fourth straight day of losses. rsted and Vestas fell XXX% and XXX% respectively while Mrsk topped the index with a XXX% gain. #investing #Denmark" [X Link](https://x.com/investseekers/status/1978125716974628986) [@investseekers](/creator/x/investseekers) 2025-10-14T15:48Z 4086 followers, 1364 engagements "Berenberg warns the 30-year luxury boom may be over citing a structural demand problem driven by Chinas slowdown and changing spending habits among young consumers. The bank downgraded #LVMH to Hold and Kering to Sell saying luxury stands at a crossroads. I disagree. People have craved luxury for millennia from gold and jewels in ancient civilizations to designer goods today. With the middle class expanding in emerging markets I doubt we are seeing structural demand problems. I currently only hold LVMH but could add Richemont at the right price and certainly also Herms which is a tier above" [X Link](https://x.com/investseekers/status/1978805379921534987) [@investseekers](/creator/x/investseekers) 2025-10-16T12:49Z 4106 followers, 1117 engagements "#WarrenBuffett more than doubled his stake in $POOL again this quarter. Its a quality business at a reasonable price and I own it too. Heres why this company deserves a closer look: #stocks #investing" [X Link](https://x.com/investseekers/status/1956086914634932692) [@investseekers](/creator/x/investseekers) 2025-08-14T20:13Z 4103 followers, XXX engagements "Zoetis ( $ZTS ) The human-animal bond is a powerful long-term driver for Zoetis. Pet owners today are younger wealthier and more committed to their pets health than ever before. Millennials and Gen Z are delaying kids but spending more on pets a secular trend boosting demand for veterinary care. Zoetis expects the animal health market to grow from $45B to $80B by 2032 driven by longer pet lifespans and chronic conditions like osteoarthritis and allergies. Its blockbuster drugs Librela Solensia and Simparica Trio show how powerful this trend already is. The livestock segment adds" [X Link](https://x.com/investseekers/status/1976964743425331589) [@investseekers](/creator/x/investseekers) 2025-10-11T10:54Z 4094 followers, XXX engagements "$GMAB s partner $JNJ reports positive phase X results from the Majestec-3 study combining Tecvayli and Darzalex Faspro. The combo showed significantly improved survival rates and longer time without disease progression compared to current standard treatments. Genmab earns royalties of 1220% on Darzalex sales and mid-single-digit royalties on Tecvayli. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1978820726024003945) [@investseekers](/creator/x/investseekers) 2025-10-16T13:50Z 4106 followers, 1054 engagements "I just read through $GMAB 's earnings call transcript and here are my notes Commitments & Progress In 2025 Genmab set three main goals: 1) Speed up development of its most important late-stage drugs. 2) Grow sales of already-approved medicines. 3) Allocate capital in ways that support long-term growth. In the first half of 2025: revenue rose XX% operating profit rose XX% and the company continued heavy investment in key programs. Cash on hand: about $3B giving flexibility for expansion. Main Growth Drivers Three drugs expected to generate major revenue by the end of the decade:Epcoritamab" [X Link](https://x.com/investseekers/status/1954122129558893010) [@investseekers](/creator/x/investseekers) 2025-08-09T10:06Z 4108 followers, 2944 engagements "The Danish C25 index closed up XXX% on Thursday. $GMAB rose XXX% after partner $JNJ reported improved survival rates in a combo cancer study with Tecvayli and Darzalex Faspro. $NVO gained XXX% as BNP Paribas Exane raised its price target to DKK XXX (from 345) while Handelsbanken cut its target to DKK XXX (from 525). #StocksToWatch #investing #Denmark" [X Link](https://x.com/investseekers/status/1978861620810883374) [@investseekers](/creator/x/investseekers) 2025-10-16T16:32Z 4104 followers, 1457 engagements "The FDA has deemed $NVO s newly acquired Indiana plant out of compliance a serious designation that could delay drug approvals for partners like $SRRK and $REGN. Issues reportedly included cat hair pests and equipment failures. Novo says fixing them is a top priority. #stocks #investing" [X Link](https://x.com/investseekers/status/1977992090396086695) [@investseekers](/creator/x/investseekers) 2025-10-14T06:57Z 4108 followers, 2654 engagements "With #Trump tariffs tanking the #StockMarket yesterday there are especially X US stocks that look interesting to me right now: $ZTS $WSO and $CPRT. If you are looking for something to research over the weekend these three are worth your time" [X Link](https://x.com/investseekers/status/1976964740963614896) [@investseekers](/creator/x/investseekers) 2025-10-11T10:54Z 4091 followers, 1381 engagements "The Danish C25 index rose XXX% on Wednesday after two days of declines. $NVO recovered from early losses to close XXX% higher at DKK XXXXXX after announcing the acquisition of assets and a license for a clinical-stage drug targeting rare blood and kidney diseases. NKT led the index rising 3.6%. #stocks #investing" [X Link](https://x.com/investseekers/status/1978560929596879187) [@investseekers](/creator/x/investseekers) 2025-10-15T20:37Z 4104 followers, 1311 engagements "$BCS has turned more positive on European healthcare stocks upgrading the sector to overweight. This could benefit major European pharma names such as $NVO Roche and $SNY which dominate the regions healthcare benchmarks. The banks strategists led by Emmanuel Cau say reduced uncertainty around drug pricing a more stable euro/dollar and cheap valuations make the sector attractive again. They highlight that healthcare is starting to recover as the euro stabilizes and U.S. demand picks up. Investor positioning which had been weak is also showing early signs of improvement. #stocks #Investing" [X Link](https://x.com/investseekers/status/1975904677611905238) [@investseekers](/creator/x/investseekers) 2025-10-08T12:42Z 4090 followers, 1155 engagements "Private equity owners are preparing a 2026 IPO for TK Elevator. I like the elevator sector there are no alternatives service is required by law and urbanization means taller buildings. I own KONE and want to buy $OTIS at the right price too. #Stocks #investing" [X Link](https://x.com/investseekers/status/1965120577615872341) [@investseekers](/creator/x/investseekers) 2025-09-08T18:30Z 4096 followers, XXX engagements "Royal Unibrew ( $RBREW ) just posted strong H1 results Volumes +4% despite cold weather in Finland (offset by strong July & Western Europe) Net revenue +3% boosted by new $PEP partnership in Belgium/Luxembourg EBIT +11% with XX bps margin expansion (better efficiency & execution) EPS +18% Very strong performance in Italy France & International segment Market share gains across most geographies New DKK 300m buyback launched 2025 guidance narrowed: XX% revenue growth XXX% EBIT growth Management says these results highlight the strength of its multi-beverage model geographic diversity and" [X Link](https://x.com/investseekers/status/1960384369551413635) [@investseekers](/creator/x/investseekers) 2025-08-26T16:50Z 4108 followers, XXX engagements "$JPM analyst Richard Vosser maintains a Buy rating on $NVO with a target price of DKK XXX. #stocks #investing" [X Link](https://x.com/investseekers/status/1975242019321655554) [@investseekers](/creator/x/investseekers) 2025-10-06T16:49Z 4095 followers, 1952 engagements "BNP Paribas Exane has raised its price target for $NVO to DKK XXX from DKK XXX while maintaining a neutral rating on the stock. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1978721320541053054) [@investseekers](/creator/x/investseekers) 2025-10-16T07:15Z 4104 followers, 1579 engagements "Just published: my analysis of $ASH.L Ashtead is one of the worlds largest equipment rental firms. Its dense branch network & metro-area clusters boost efficiency cut delivery times & give it an edge over smaller rivals. Read it here: #stocks #invest" [X Link](https://x.com/investseekers/status/1956597284151378214) [@investseekers](/creator/x/investseekers) 2025-08-16T06:01Z 4109 followers, XXX engagements "@StenAndersen13 @seep2p It would be illegal for Novo Nordisk not to disclose the data if they already had it. That said they might have preliminary indications or trends from the EVOKE/EVOKE+ trials but not the full validated results yet" [X Link](https://x.com/investseekers/status/1979076603473744328) [@investseekers](/creator/x/investseekers) 2025-10-17T06:46Z 4106 followers, XXX engagements "#WarrenBuffett emphasizes that integrity is the most critical quality in management believing that a lack of it is disastrous even in intelligent and energetic individuals. I don't think I could ever invest in $HIMS" [X Link](https://x.com/investseekers/status/1979104102186426436) [@investseekers](/creator/x/investseekers) 2025-10-17T08:36Z 4108 followers, 3359 engagements "#LeBronJames and Hennessy just launched a limited-edition Hennessy V.S.O.P bottle designed with LeBron available in select markets this month. Hennessy is part of Mot Hennessy owned XX% by $MC.PA and XX% by $DEO. Both #LVMH and Diageo shares are up today. #stocks #Investing" [X Link](https://x.com/investseekers/status/1975611956774961646) [@investseekers](/creator/x/investseekers) 2025-10-07T17:19Z 4101 followers, XXX engagements "Sweden has produced some exceptional serial acquirers that have delivered strong long-term returns for shareholders. One of the best is $ADDT. I just published my full analysis of the company read it here: #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1979423183900967027) [@investseekers](/creator/x/investseekers) 2025-10-18T05:43Z 4108 followers, XXX engagements "$TEP.PA has dropped from XXX to under XXX on AI fears but the company sees AI as a long-term tailwind not a threat. Full analysis here: #StocksToWatch #InvestingTips" [X Link](https://x.com/investseekers/status/1933028237149343973) [@investseekers](/creator/x/investseekers) 2025-06-12T05:07Z 4105 followers, XXX engagements "Novo Nordisk is down over XX% year-on-yearbut Jyske Bank calls it a golden buying opportunity. Despite short-term uncertainty the bank says $NVO has some of the sectors most attractive growth prospects with expected annual sales growth of XX% through 2027 (vs. X% for the sector). Novo now trades at half the valuation of $LLY even though they were similarly priced a year ago. Jyskes price target DKK 850implying more than XXX% upside. #StocksToBuy #Investing" [X Link](https://x.com/investseekers/status/1915078965435437297) [@investseekers](/creator/x/investseekers) 2025-04-23T16:23Z 4086 followers, 10.8K engagements "$NVO has hired $ABBV 's Greg Miley as its new SVP of Corporate Affairs. Greg Miley a pharma veteran with nearly XX years of experience in government and public affairs previously led global policy and legislative strategy at AbbVie and held senior roles at Sanofi and Pfizer. He is also a board member of the Public Affairs Council and has extensive experience navigating U.S. healthcare policy and drug pricing debates which will be valuable given Novos current challenges in the U.S. market. He will relocate to Denmark to lead Novo Nordisks global communications and public affairs. Hopefully" [X Link](https://x.com/investseekers/status/1979250181188079743) [@investseekers](/creator/x/investseekers) 2025-10-17T18:16Z 4108 followers, 2270 engagements "I just did a quick back-of-the-envelope calculation: #Prosus owns 2091.4M #TENCENT shares. With Tencent closing at XXXXXX HKD thats worth about 155.5B. Divided by Prosuss 2.19B shares outstanding = XXXX per share in Tencent value. Prosus trades at XXXX meaning you are getting Tencent at a discount and everything else Prosus owns for free. Prosus remains my largest position. #stocks #investing" [X Link](https://x.com/investseekers/status/1976213142439915576) [@investseekers](/creator/x/investseekers) 2025-10-09T09:08Z 4107 followers, XXX engagements "The Danish C25 index fell XXX% on Thursday. $NVO made headlines after announcing the $XXX billion acquisition of U.S. biotech Akero Therapeutics its largest R&D deal ever. The market reaction was muted with Novo Nordisk shares ending the day down 1.3%. Meanwhile Maersk shares declined as progress in Middle East peace talks weighed on shipping stocks. #stocks #investing #Denmark" [X Link](https://x.com/investseekers/status/1976323898116362396) [@investseekers](/creator/x/investseekers) 2025-10-09T16:28Z 4091 followers, 1384 engagements "The Danish C25 index managed to turn green after spending most of the day in red finishing up +0.14%. Todays winners: GN Store Nord +19.9% NKT +3.3% $NVO +3.0% $GMAB +2.0% Vestas +1.5% Todays losers: Novonesis -XXX% Coloplast -XXX% Nordea -XXX% DSV -XXX% Royal Unibrew -XXX% #stocks #investing" [X Link](https://x.com/investseekers/status/1958578596110385363) [@investseekers](/creator/x/investseekers) 2025-08-21T17:15Z 4086 followers, XXX engagements "Financial Times dives into what it calls $NVO s lottery ticket the Danish drugmakers upcoming Alzheimers trials using its blockbuster semaglutide (Wegovy/Ozempic). Two large phase X studies testing the drug in thousands of early-stage patients could reveal whether GLP-1s can slow or even alter the disease a potential breakthrough for the 55M people living with dementia. Novo execs describe the trials as high-risk high-reward. After the stocks XX% drop over the past year positive data could be transformative. Some studies already suggest semaglutide users have a XX% lower dementia risk" [X Link](https://x.com/investseekers/status/1978350124418932946) [@investseekers](/creator/x/investseekers) 2025-10-15T06:40Z 4108 followers, 14.3K engagements "Euroinvestor looked at analyst targets for Denmarks C25 stocks. The X with the highest upside over the next XX months: X Zealand Pharma +67% X Ambu +44% X DSV +40% X Demant +34% X GN Store Nord +32% $ZEAL tops the list despite falling XX% in the past year. I own a small position in Zealand Pharma none of the others. Link to article (in Danish): #stocks #investing #Denmark" [X Link](https://x.com/investseekers/status/1973258805992419559) [@investseekers](/creator/x/investseekers) 2025-10-01T05:28Z 4104 followers, XXX engagements "The sharp share price drop in $NVO this year is a clear overreaction according to Danish wealth manager Formue & Investeringspleje. They note that Novo is trading at a forward P/E of XX compared to XXXX for the global index arguing the market is undervaluing Novos long-term growth in obesity treatments. #stocks #investing" [X Link](https://x.com/investseekers/status/1978007743047877097) [@investseekers](/creator/x/investseekers) 2025-10-14T07:59Z 4101 followers, 2837 engagements "$MORN just asked the big question: is it time to buy Danish stocks The Morningstar Denmark Index is the worst-performing index globally in 2025 down XXXX% YTD and XXXX% in XX months. Key drivers: $NVO with a XX% index weight is down nearly XX% in a year dragging the entire market lower. Orsted and Vestas slumped as green energy faces falling prices nuclear competition and US policy headwinds. Orsted shares are -XX% YoY after an 8.1B rights issue and a US stop-work order on Revolution Wind. US-Denmark tensions add risk with Trumps revived push to buy Greenland raising speculation around US" [X Link](https://x.com/investseekers/status/1968898596490691070) [@investseekers](/creator/x/investseekers) 2025-09-19T04:43Z 4106 followers, 1814 engagements "#Carlsberg now expects 110m in synergies from its 29bn Britvic acquisition up from 100m. CEO Jacob Aarup-Andersen says that after 8+ months of integration nothing unexpected has surfaced and more staff overlaps mean bigger cost savings. I believe $CARLB trades at an attractive valuation but is it enough to buy I wrote more here: #stocks #investing #beer" [X Link](https://x.com/investseekers/status/1973360748295250056) [@investseekers](/creator/x/investseekers) 2025-10-01T12:14Z 4085 followers, XXX engagements "#Prosus repurchased 1264403 $PRX shares last week at an average price of XXXXX per share. The company has been buying back shares every week since June 2022. It remains my largest position ahead of $NVO and $BABA. #stocks #investing" [X Link](https://x.com/investseekers/status/1978380700660199909) [@investseekers](/creator/x/investseekers) 2025-10-15T08:41Z 4109 followers, 1467 engagements "Danish financial media outlet konomisk Ugebrev has written an excellent deep dive on $PFE s $70/share acquisition of U.S. obesity biotech Metsera revealing just how intense the bidding war was. According to Metseras SEC filing six major pharma companies - including Pfizer and likely rivals such as $NVO or $LLY - were involved. Pfizer ultimately secured the deal with an offer of $XXXXX in cash plus $XXXXX in milestone payments narrowly beating a rival bid of $87/share that fell apart due to regulatory hurdles. Metseras amylin-based obesity candidates (MET-097i and MET-233i) have significant" [X Link](https://x.com/investseekers/status/1979139576586276948) [@investseekers](/creator/x/investseekers) 2025-10-17T10:57Z 4108 followers, 1325 engagements "Theres plenty of upside potential in Danish large-cap #stocks at least according to analyst estimates compiled by Euroinvestor from Bloomberg data. Analysts top pick is Zealand Pharma whose average price target suggests +54% upside despite the stock being down over XX% this year. Other C25 stocks with strong potential include: DSV +33% Ambu +29% Pandora +29% GN Store Nord +26% Carlsberg +24% Demant +23% Rockwool +22% Coloplast +20% Novonesis +19% Link to article (in Danish): #StocksToWatch #investing #Denmark" [X Link](https://x.com/investseekers/status/1978784048022536300) [@investseekers](/creator/x/investseekers) 2025-10-16T11:24Z 4100 followers, XXX engagements "I just read through the earnings call transcript of #LVMH and here are my notes: Growth in Q3 LVMH returned to organic growth up X% in Q3 (4% reported after a X% FX hit). All other divisions also grew organically with Selective Retailing (Sephora) standing out. Regional trends Mainland Chinas local sales returned to growth while total spending by Chinese consumers (local + tourist) was still slightly negative but improving. The U.S. improved sequentially from Q2. Japan rebounded after tough comps. Europe was broadly stable but slightly impacted by softer tourism. Southeast Asia remained weak" [X Link](https://x.com/investseekers/status/1978707437029876082) [@investseekers](/creator/x/investseekers) 2025-10-16T06:19Z 4109 followers, 1372 engagements "Yesterday news broke that $NVO is ending its work and research in cell therapy. It is a bold move under new CEO Mike Doustdar who has repeatedly said Novo should focus on its core in diabetes obesity and cardiovascular disease. Former CEO Lars Fruergaard Jrgensen once called cell therapy a decisive project for Novo noting the company had worked on it for XX years. Mike Doustdars decision marks a clear shift from pursuing every opportunity to doubling down on what works. It is early days but Novo now appears leaner more focused and more pragmatic under his leadership. #stocks #investing" [X Link](https://x.com/investseekers/status/1977051065129283912) [@investseekers](/creator/x/investseekers) 2025-10-11T16:38Z 4100 followers, 6829 engagements "$NVO is rewarded by investors after Wegovy was approved in the US for treating fatty liver disease (MASH). According to Nordnets Per Hansen the positive sentiment could also spill over to $ZEAL . Zealand Pharma together with its partner Boehringer Ingelheim initiated two Phase X studies in October 2024 to test their drug candidate Survodutide against MASH. The trials are designed to run for XX weeks with results expected in the first half of 2026. Fatty liver (MASH) has long been a key focus for Zealand Pharma and the company has previously stated hopes that Survodutide could become a" [X Link](https://x.com/investseekers/status/1957342072681169370) [@investseekers](/creator/x/investseekers) 2025-08-18T07:21Z 4108 followers, 2463 engagements "#prosus just unveiled the Large Commerce Model an AI system built to rethink how ecommerce works. Instead of using traditional search and recommendation engines The Large Commerce Model understands what people are looking for and why. Its trained on data from over XXX million users and XX trillion data points constantly learning to make online shopping more personal and intuitive. The model is already showing results across Prosuss global portfolio including iFood OLX eMag and Despegar with: X higher click-through rates on notifications XX% boost in personalised recommendations XXX% lift in" [X Link](https://x.com/investseekers/status/1976569687199580285) [@investseekers](/creator/x/investseekers) 2025-10-10T08:45Z 4107 followers, 1184 engagements "$NVO CEO Mike Doustdar tells Danish business daily Brsen about the companys acquisition of Akero Therapeutics: We believe efruxifermin could become a cornerstone therapy alone or together with Wegovy to tackle one of the fastest-growing metabolic diseases of our time. #stocks #investing" [X Link](https://x.com/investseekers/status/1976242109809152340) [@investseekers](/creator/x/investseekers) 2025-10-09T11:03Z 4091 followers, 2835 engagements "@JacobCordosa Lets see. Premarket $NVO and $LLY are down roughly the same" [X Link](https://x.com/investseekers/status/1979158113539277228) [@investseekers](/creator/x/investseekers) 2025-10-17T12:10Z 4109 followers, XXX engagements "A professional jury has named Novo Nordisk Foundation and Novo Holdings the controlling owners of $NVO leaders Kasim Kutay Mads Krogsgaard Thomsen and Lars Rebien Srensen as Denmarks Business Profiles of the Year 2025. The award recognizes their leadership behind major contributions to Danish business and society including Novo Holdings acquisition of Catalent support for the NovozymesChr. Hansen merger that created Novonesis and the Foundations record funding for research and sustainability. Kutay has transformed Novo Holdings with record returns and a growing focus on green investments." [X Link](https://x.com/investseekers/status/1976521621956391223) [@investseekers](/creator/x/investseekers) 2025-10-10T05:34Z 4094 followers, 2795 engagements "According to Danish newspaper Brsen $NVO was reportedly one of the bidders for biotech firm Metsera which was ultimately acquired by $PFE in September for $XXX billion. Documents from Metsera show that two companies offered more than Pfizer yet Pfizer still won the deal. Analysts at BMO Capital Markets believe Novo Nordisk was likely Party X one of the losing bidders given its dominant position in the GLP-1 and amylin markets and the timing of the talks shortly after CagriSemas disappointing data in December 2024. According to the documents Novo reportedly bid $X billion in cash in January" [X Link](https://x.com/investseekers/status/1975854204955537441) [@investseekers](/creator/x/investseekers) 2025-10-08T09:22Z 4101 followers, 3015 engagements "The Gates Foundation and Pan American Health Organization (PAHO) are exploring ways to make weight-loss drugs like $NVO s Wegovy and $LLY s Mounjaro more accessible in low-income countries Reuters reports. Bill Gates said his foundation aims to take drugs proven in rich countries and make them super super cheap so they can reach everyone. PAHO chief Dr. Jarbas Barbosa added that the organization is preparing usage guidelines and plans to meet with Novo Nordisk Lilly and generic makers in the coming weeks to discuss broader access. #stocks #investing" [X Link](https://x.com/investseekers/status/1976577551356014909) [@investseekers](/creator/x/investseekers) 2025-10-10T09:16Z 4091 followers, 2659 engagements "$NVO just lost its lawsuit against the US government over Medicare drug price negotiations marking the 15th straight court defeat for Big Pharma. A federal appeals court rejected Novos claims that the program violates the Constitution siding with earlier rulings against $AZN and $BMY. The news may help explain why Novo shares are down today. Starting in 2026 Medicare will negotiate lower prices on its first batch of drugs expected to save patients $1.5B and taxpayers $6B in the first year. Full story: #stocks #Investing" [X Link](https://x.com/investseekers/status/1975466873228562613) [@investseekers](/creator/x/investseekers) 2025-10-07T07:42Z 4106 followers, 2469 engagements "BMO Capital Markets has raised its price target for $NVO s U.S.-listed ADR to $XX ( DKK 355.44) from $XX while maintaining a market perform rating. The new target is about XXX% below Novos current U.S. share price of $XXXXX. #stocks #investing" [X Link](https://x.com/investseekers/status/1978034041682108538) [@investseekers](/creator/x/investseekers) 2025-10-14T09:44Z 4100 followers, 1669 engagements "Should you buy $NVO right now Analysts are split: Morgan Stanley cut it to underweight while HSBC upgraded it to buy. With oral Wegovy awaiting FDA approval and Alzheimers data coming in 202526 Novo might appeal to speculative investors looking for upside. Link to article: #stocks #investing" [X Link](https://x.com/investseekers/status/1977426790575431691) [@investseekers](/creator/x/investseekers) 2025-10-12T17:31Z 4107 followers, 4317 engagements "Where do analysts see the biggest upside among Danish large caps According to Bloomberg data compiled by Euroinvestor analysts believe several C25 #stocks are trading far below fair value with five names standing out for their potential double-digit gains: X Zealand Pharma top pick seen rising XX% over the next year as analysts target DKK XXXXX vs. Fridays XXXXX. X DSV logistics giant with XX% upside after a weak year. X Pandora analysts see XX% upside despite a XX% drop YTD. X Ambu medical device maker with XX% potential. X Demant hearing aid group seen climbing 29%. Overall analysts expect" [X Link](https://x.com/investseekers/status/1977663474781094142) [@investseekers](/creator/x/investseekers) 2025-10-13T09:11Z 4109 followers, 1190 engagements "Jumbo Interactive ( $JIN ) jumps +8% after announcing its entry into the UK prize draw market with the acquisition of Dream Car Giveaways a leading B2C platform offering car cash and lifestyle prizes. The deal worth A$109.9M marks Jumbos biggest step yet in expanding internationally. DCG generated A$118M in TTV and A$17.9M in revenue over the past year and the acquisition is expected to be EPS accretive within XX months. With a 6.5x EBITDA multiple and 2025% EBITDA growth expected the deal looks like a strong strategic move and despite todays jump the shares still look cheap. Read my full" [X Link](https://x.com/investseekers/status/1978365223766569230) [@investseekers](/creator/x/investseekers) 2025-10-15T07:40Z 4100 followers, XXX engagements "$DB has raised its price target on $GMAB by X% to DKK 2000 from DKK 1900 while maintaining a Buy rating. Despite the upgrade the new target sits slightly below Fridays closing price of DKK 2100 implying limited near-term upside. Genmabs shares are up XX% in 2025 and nearly XX% since Aprils low boosted by this weeks DKK 51B acquisition of Dutch biotech Merus which alone sent the stock up 14%. Deutsche Bank has rated the stock Buy since November 2023 when it traded around DKK 2153. #stocks #investing" [X Link](https://x.com/investseekers/status/1975080580329972007) [@investseekers](/creator/x/investseekers) 2025-10-06T06:08Z 4100 followers, 1072 engagements "$BCS has upgraded $ROCKB to Overweight from Equal Weight and raised its price target by DKK XX to DKK XXX implying XX% upside. I dont own Rockwool but its on my watch list. Energy efficiency is one of the strongest structural growth drivers for the company. Buildings account for nearly one-third of global energy use and CO emissions and insulation is among the most cost-effective ways to reduce both. Rockwools stone wool insulation can cut heating needs by up to 70%. With the EUs new Energy Performance of Buildings Directive and rising global efficiency standards Rockwool is well positioned" [X Link](https://x.com/investseekers/status/1976204989614678283) [@investseekers](/creator/x/investseekers) 2025-10-09T08:36Z 4104 followers, XXX engagements "I still agree that $NVO is one of the best deals in the market" [X Link](https://x.com/investseekers/status/1978180019747684364) [@investseekers](/creator/x/investseekers) 2025-10-14T19:24Z 4101 followers, 8293 engagements "Danish financial outlet konomisk Ugebrev writes about $NVO s latest move in the obesity market. Novo shares rose X% yesterday after the company outlined plans to launch its upcoming weight-loss pill in the US through telehealth platforms once FDA approval arrives (expected H1 2026). US head Dave Moore says the strategy will help Novo regain ground from $LLY and leverage the strong brand awareness built through Ozempic and Wegovy. Novo is also considering subscription models and will produce the pill in the US to strengthen supply and market presence. This follows news that Novo will" [X Link](https://x.com/investseekers/status/1975457010234581149) [@investseekers](/creator/x/investseekers) 2025-10-07T07:03Z 4091 followers, 1974 engagements "Investors are rattled by Trumps comments sending $NVO shares sharply lower says Claus Johansen CEO of Global Health Invest. Trump said Ozempic prices could drop to $XXX a month from around $1000 sparking fears about the ongoing U.S. price negotiations under the Inflation Reduction Act set to conclude Nov. X 2025. The outcome due Nov. XX could be decisive for Novo Nordisk if Ozempic Wegovy and Rybelsus are included. Johansen notes that the sell-off reflects fears of lower Medicare and Medicaid revenue though Trumps suggested cuts imply an even steeper impact. Johansen who holds no Novo shares" [X Link](https://x.com/investseekers/status/1979193810165871029) [@investseekers](/creator/x/investseekers) 2025-10-17T14:32Z 4108 followers, 2314 engagements "$BABA s multibillion-dollar AI push is starting to pay off. According to comments from its e-commerce division in October Alibaba has already seen a XX% increase in ad returns after boosting its $53B AI and cloud budget a rare double-digit gain driven by smarter search and virtual try-ons. CEO Wu Yongming calls this a historic investment phase to build an AI-powered e-commerce and cloud platform. Link to article: #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1978816574791258553) [@investseekers](/creator/x/investseekers) 2025-10-16T13:33Z 4106 followers, 2008 engagements "$LLY s oral weight-loss drug Orforglipron was not among the nine new medicines granted priority review by the U.S. FDA despite expectations it might be. It adds to a tough day for Lilly with Trumps renewed criticism of high obesity drug prices also weighing on shares. $C wasnt surprised by the omission while $JPM 's Chris Schott noted another FDA update is expected in the coming months and said we wouldnt be surprised to see Orforglipron included then. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1979203429701496920) [@investseekers](/creator/x/investseekers) 2025-10-17T15:10Z 4108 followers, 1517 engagements "Watsco ( $WSO ) There are over XXX million HVAC units in service across the US and the installed base grows every year. Most of Watscos business comes from replacements not new construction. When a system breaks it must be replaced making this one of the most resilient industrial markets around. Watscos growth is powered by: A steady replacement cycle (820 years) The shift from gas furnaces to electric heat pumps (more frequent replacements) A strong acquisition track record (70+ deals since 1989) Digital innovation e-commerce now drives $2.6B in sales (35% of revenue) Its tech investments" [X Link](https://x.com/investseekers/status/1976964746063601915) [@investseekers](/creator/x/investseekers) 2025-10-11T10:55Z 4094 followers, XXX engagements "$NVO is ending its work and research in cell therapy resulting in around XXX layoffs reports Finans a Danish financial news outlet. In an email to the outlet Novo confirmed: We have decided to stop our research and development activities within cell therapy. The decision is part of the large round of layoffs that began in September. The unit had been researching treatments for Parkinsons chronic heart failure and type X diabetes. #stocks #investing" [X Link](https://x.com/investseekers/status/1976717366059766155) [@investseekers](/creator/x/investseekers) 2025-10-10T18:32Z 4100 followers, 3012 engagements "@ResearchPulse1 No. It was a report from Market Wire which refers to Morgan Stanley" [X Link](https://x.com/investseekers/status/1978099659005452330) [@investseekers](/creator/x/investseekers) 2025-10-14T14:04Z 4086 followers, XXX engagements "Nordea raises its price target on $CHEMM to DKK XXX from DKK XXX maintaining a Buy rating. Probably my favorite Danish small cap. You can read why in my analysis here: #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1979271949311184965) [@investseekers](/creator/x/investseekers) 2025-10-17T19:43Z 4108 followers, XXX engagements "Billionaire investor Chris Hohn founder of TCI Fund Management explains why he bought $AENA at its IPO and still holds it today: Ive always liked infrastructure. Its boring toll roads airports cell towers but you dont lose your capital. When Spain IPOd Aena it was a monopoly of irreplaceable airports sold at a XX% free cash flow yield. Youll never rebuild Madrid or Barcelona airports. Full analysis of Aena: #stocks #investing #Airport" [X Link](https://x.com/investseekers/status/1977092210693681390) [@investseekers](/creator/x/investseekers) 2025-10-11T19:21Z 4104 followers, 1836 engagements "$BAC cuts its price target on $ZEAL to DKK XXX from XXX citing intensifying competition in obesity drug development. BofA says $LLY s upcoming phase X data on amylin candidate Eloralintide is the biggest risk setting a new benchmark ahead of Zealand Pharma and Roches Petrelintide readout in H1 2026. #Stocks #investing #obesity" [X Link](https://x.com/investseekers/status/1963542031201870036) [@investseekers](/creator/x/investseekers) 2025-09-04T09:57Z 4109 followers, XXX engagements "@Mike_Tradewatch I'm quite confident that demand holds for all three companies. I understand that tariffs can affect $WSO but why wouldn't demand hold for $CPRT" [X Link](https://x.com/investseekers/status/1977002601779806277) [@investseekers](/creator/x/investseekers) 2025-10-11T13:25Z 4087 followers, XXX engagements "$NVO is buying $AKRO for $4.7B (plus a potential $0.5B bonus) to expand its pipeline for liver disease treatments. Akeros main drug efruxifermin is the only medicine so far to show it can reverse liver scarring in advanced-stage MASH patients. Its now in phase X trials. Novo believes it could become a key treatment for MASH a serious liver disease linked to obesity and possibly work alongside Wegovy. The deal strengthens Novos position in metabolic diseases and supports its long-term growth strategy. #stocks #investing" [X Link](https://x.com/investseekers/status/1976236195475517635) [@investseekers](/creator/x/investseekers) 2025-10-09T10:40Z 4091 followers, 7051 engagements "I just read through $NVO s M&A call transcript about the Akero Therapeutics acquisition and here are my notes Why Novo Nordisk is buying Akero Novo Nordisk is acquiring Akero Therapeutics for about $XXX billion to get its late-stage drug efruxifermin (EFX) which targets MASH a serious liver disease closely linked to obesity and diabetes. More than XX% of MASH patients are overweight or obese so this fits perfectly with Novos focus on metabolic diseases. Around XXX million people suffer from MASH globally and the number is growing fast. Novo already entered the space in August when Wegovy" [X Link](https://x.com/investseekers/status/1976339879173779954) [@investseekers](/creator/x/investseekers) 2025-10-09T17:32Z 4109 followers, 21.5K engagements "#DonaldTrump says the price of Ozempic $NVO s diabetes drug will soon be much cheaper in the US. Speaking at a White House event on fertility and drug pricing Trump said negotiations are moving quickly and specifically named Ozempic calling it that weight-loss drug. Novo Nordisk confirmed its in talks with the Trump administration about improving affordability and access but did not comment directly on Trumps remarks. Trump has previously said the monthly cost could drop from $1300 to $XXX. Novo already cut its list price by half in September to $XXX for uninsured patients. Ozempic is also" [X Link](https://x.com/investseekers/status/1979058223362523349) [@investseekers](/creator/x/investseekers) 2025-10-17T05:33Z 4108 followers, 9109 engagements "$CPRT is down XX% this year trading at its lowest valuation since 2017. Its still one of the highest-quality businesses in the market but does that make it a buy now I just updated my analysis here: #StocksToWatch #Investing" [X Link](https://x.com/investseekers/status/1974920274098159693) [@investseekers](/creator/x/investseekers) 2025-10-05T19:31Z 4086 followers, 1410 engagements "I opened a position in $LSEG.L London Stock Exchange Group is far more than an exchange. XX% of its revenue is high-margin recurring subscriptions from data analytics indices & risk tools. It also owns LCH which clears most of the worlds interest rate swap trades. The stock trades at a discount because Annual Subscription Value growth slowed during the migration from Eikon to Workspace and due to competitor discounting. Management says these are short-term issues pointing out they have seen rivals cut prices before it wasnt sustainable then and wont be now. Today LSEG trades at its highest" [X Link](https://x.com/investseekers/status/1969050125088489617) [@investseekers](/creator/x/investseekers) 2025-09-19T14:45Z 4100 followers, 1729 engagements "@inversionmedica Im just summarizing the article. Personally I dont consider $NVO speculative it is my second-largest position" [X Link](https://x.com/investseekers/status/1977439134072668429) [@investseekers](/creator/x/investseekers) 2025-10-12T18:20Z 4094 followers, XXX engagements "The Novo Nordisk Foundation the main owner of $NVO through Novo Holdings is funding a major new global health initiative the Global Pathogen Analysis Platform (GPAP) with up to DKK XXX million to strengthen pandemic preparedness worldwide. Based at DTU with partners at University of Copenhagen Statens Serum Institut and Imperial College London GPAP will use AI-powered genomic analysis to detect and track infectious diseases and will be free to use globally. Fragmented surveillance has left the world vulnerable said Lene Oddershede from the Novo Nordisk Foundation. GPAP will provide a secure" [X Link](https://x.com/investseekers/status/1977634305611297098) [@investseekers](/creator/x/investseekers) 2025-10-13T07:15Z 4105 followers, 2028 engagements "Algeria and $NVO have signed a strategic deal to boost local insulin production in partnership with state-owned pharma group Saidal. The agreement aims to enhance pharmaceutical sovereignty reduce imports and improve access for Algerias 4M diabetes patients 1.5M of whom depend on insulin. Novo Nordisk will transfer technology and expertise to Saidal to establish a world-class aseptic production facility ensuring international quality standards and long-term healthcare resilience. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1979072635817595187) [@investseekers](/creator/x/investseekers) 2025-10-17T06:31Z 4108 followers, 1846 engagements "@unusual_whales Warren Buffett emphasizes that integrity is the most critical quality in management believing that a lack of it is disastrous even in intelligent and energetic individuals. I don't think I could ever invest in $HIMS" [X Link](https://x.com/investseekers/status/1979218398169932259) [@investseekers](/creator/x/investseekers) 2025-10-17T16:10Z 4108 followers, 16.6K engagements "Danske Bank analyst Mads Zink on $NVO s rise after EU label expansion for Rybelsus: The approval was XXX% expected. The stock is up because its a positive in whats been a stretch of negative news. A series of small positives can shift momentum. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1967630742504018218) [@investseekers](/creator/x/investseekers) 2025-09-15T16:45Z 4100 followers, 1351 engagements "$GMAB s DKK 51B ($7.5B) acquisition of Dutch biotech Merus gives the Danish company access to petosemtamab a late-stage cancer drug with multi-blockbuster potential. Analysts highlight that the deal addresses one of Genmabs biggest challenges: bridging the patent cliff expected from 2030 when revenues from its blockbuster Darzalex begin to fade. Petosemtamab has shown highly promising Phase X results in head and neck cancer where current first-line treatments like Mercks Keytruda or chemotherapy deliver X year average survival. In comparison petosemtamab showed XX% survival after one year." [X Link](https://x.com/investseekers/status/1972635075557953967) [@investseekers](/creator/x/investseekers) 2025-09-29T12:10Z 4100 followers, 1670 engagements "These X companies Zoetis Watsco and Copart operate in very different industries but they share one trait: structural long-term growth independent of short-term market noise" [X Link](https://x.com/investseekers/status/1976964750572683741) [@investseekers](/creator/x/investseekers) 2025-10-11T10:55Z 4086 followers, XXX engagements "Handelsbanken has lowered its price target for $NVO to DKK XXX from DKK XXX while keeping a buyrating. The bank cut its Ozempic forecast due to weaker U.S. prescription trends and concerns over IRA price negotiations but still expects XX% revenue growth in 2026 driven entirely by Wegovy. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1978730128419979631) [@investseekers](/creator/x/investseekers) 2025-10-16T07:50Z 4108 followers, 1866 engagements "$NVO launching Wegovy in Argentina now approved for both adults and teens (12+)" [X Link](https://x.com/investseekers/status/1978160566830084362) [@investseekers](/creator/x/investseekers) 2025-10-14T18:06Z 4086 followers, XXX engagements "@baselineX2024 No I havent. But I know that $LLY has increased prices which should mean $NVO could gain market share. I tweeted about it some time ago but I havent seen any specific news over the weekend. What is the news" [X Link](https://x.com/investseekers/status/1977420060517138467) [@investseekers](/creator/x/investseekers) 2025-10-12T17:04Z 4094 followers, XXX engagements "@sudokhanh @unusual_whales My portfolio is public. You can read more about where to see it here:" [X Link](https://x.com/investseekers/status/1979258395182981267) [@investseekers](/creator/x/investseekers) 2025-10-17T18:49Z 4108 followers, XXX engagements "$NVO has faced a tough few months with layoffs policy uncertainty and pressure on its U.S. growth outlook. But according to a new report from JPMorgan the long-term picture still looks promising. $JPM now expects Novo to see low to mid single-digit growth (around 34%) in 2026 and 2027 as pricing headwinds from the Trump administrations Most Favoured Nation policy and upcoming Medicare negotiations temporarily weigh on results. The bank expects the company to lower U.S. prices for Ozempic and Wegovy in line with international levels. However from 2028 onward growth is expected to reaccelerate" [X Link](https://x.com/investseekers/status/1976264507405083126) [@investseekers](/creator/x/investseekers) 2025-10-09T12:32Z 4109 followers, 2790 engagements "$DB says Novo Nordisks Wegovy pill could play a key role in both diabetes & obesity. After EASD data from $NVO & $LLY analyst Emmanuel Papadakis notes oral semaglutide will have a role in both markets. Deutsche Bank keeps a Buy rating on Novo with a DKK XXX PT. #stocks #investing" [X Link](https://x.com/investseekers/status/1968622904645394759) [@investseekers](/creator/x/investseekers) 2025-09-18T10:27Z 4097 followers, 1657 engagements "Per Hansen investment economist at Nordnet notes that when Donald Trump says jump investors still do sometimes even on old news. After Trump repeated Thursday that the price of Ozempic will soon be much cheaper in the U.S. $NVO s ADRs fell X% post-market. Trump just repeated his old line weight-loss drug prices will come down. Investors react again even though theres nothing new says Hansen. Ozempic/Wegovy has been part of Medicare price negotiations since January with results expected in the coming months and taking effect from 2027. Hansen adds that this is a non-news reaction prices are" [X Link](https://x.com/investseekers/status/1979087231529918636) [@investseekers](/creator/x/investseekers) 2025-10-17T07:29Z 4108 followers, 6207 engagements "The Danish C25 index closed down XXX% on Tuesday as several healthcare stocks came under pressure. $NVO was the biggest loser of the day falling XXX% with most of the decline coming after U.S. trading began. #stocks #Investing #Denmark" [X Link](https://x.com/investseekers/status/1975596479910719756) [@investseekers](/creator/x/investseekers) 2025-10-07T16:18Z 4100 followers, XXX engagements "$NVO and $LLY could be heading for the next big battle not in diabetes but Alzheimers. Novos Rybelsus may protect brain blood vessels and slow Alzheimers progression while Lillys cheaper oral GLP-1 drug orforglipron could make the approach viable at scale. The race for the first Alzheimers pill is heating up. Full article: #stocks #Investing" [X Link](https://x.com/investseekers/status/1975428372135100682) [@investseekers](/creator/x/investseekers) 2025-10-07T05:10Z 4097 followers, 5703 engagements "Copart ( $CPRT ) Coparts business runs on auction liquidity the more bidders per car the higher the sale price. That flywheel is powerful: More buyers higher prices more sellers even more buyers. Coparts average selling prices rose XXX% in FY25 beating broader used-car indices. Beyond insurance vehicles Copart is growing with rental fleets banks and dealers which diversifies supply and strengthens the platform. Rising repair costs (especially with EVs) mean more totaled cars fueling long-term supply. Copart combines network effects scale and capital efficiency in a business that keeps" [X Link](https://x.com/investseekers/status/1976964748588581369) [@investseekers](/creator/x/investseekers) 2025-10-11T10:55Z 4086 followers, XXX engagements "$NVO s oral obesity drug Monlunabant (INV-202) showed promising Phase 2a results published in The Lancet Diabetes & Endocrinology. In a 16-week trial with XXX adults patients lost X kg vs XXX kg on placebo with improvements in glucose and lipid levels. Monlunabant works by blocking CB1 receptors outside the brain helping reduce fat storage and improve metabolism while avoiding the mood-related side effects that hurt earlier CB1 drugs. Novo Nordisk plans to test it in larger Phase 2b studies as a potential new oral treatment for obesity and related metabolic disorders. Link to article: #stocks" [X Link](https://x.com/investseekers/status/1979284029599076749) [@investseekers](/creator/x/investseekers) 2025-10-17T20:31Z 4108 followers, 2978 engagements "Investors are selling $NVO shares on Monday after renewed pressure on the stock. According to Sydbank several factors are weighing on the Danish drugmaker. SEB cut its price target from DKK XXX to XXX citing weaker Ozempic sales in the U.S. and lower growth expectations toward 2026 though it still sees XX% upside over the next XX months. Novo also faces new scrutiny over potential side effects of Wegovy Ozempic and Rybelsus after the EMA added warnings about a rare eye condition (NAION). Adding to the uncertainty recent price-cut deals between Donald Trump and Pfizer/AstraZeneca could" [X Link](https://x.com/investseekers/status/1977702398236741670) [@investseekers](/creator/x/investseekers) 2025-10-13T11:46Z 4101 followers, 2294 engagements "The Danish C25 index closed down XXX% today driven by weakness in healthcare stocks. $NVO fell XXX% after U.S. President Donald Trump renewed his focus on drug prices putting pressure on the sector. $ZEAL was the biggest loser of the day down 8.4%. #stocks #investing" [X Link](https://x.com/investseekers/status/1979235459784958422) [@investseekers](/creator/x/investseekers) 2025-10-17T17:18Z 4108 followers, XXX engagements "$JEF says $BABA s growth momentum likely remained strong in the September quarter. Customer management revenue is expected to rise XX% YoY supported by solid traffic growth in on-demand delivery. Cloud growth also likely accelerated driven by strong AI demand and Alibabas full-stack AI infrastructure. Jefferies keeps Alibaba as its top pick for 2026 with a Buy rating and a $XXX target price (vs $XXXXXX last). #stocks #investing" [X Link](https://x.com/investseekers/status/1976232923691966540) [@investseekers](/creator/x/investseekers) 2025-10-09T10:27Z 4107 followers, 1017 engagements "The Danish C25 index rose XXX% on Monday. Hearing aid maker GN Store Nord led the gains jumping X% despite no company-specific news. $NVO shares also climbed X% after reports over the weekend that $COST customers in the U.S. will soon be able to buy Ozempic and Wegovy at about half price in stores. #stocks #investing #Denmark" [X Link](https://x.com/investseekers/status/1975219555489218909) [@investseekers](/creator/x/investseekers) 2025-10-06T15:20Z 4107 followers, 1315 engagements "$DPZ reports earnings tomorrow. #WarrenBuffett has been buying shares recently and for good reason. Its the worlds largest pizza chain built on delivery carryout and an asset-light franchise model that keeps margins strong. My full analysis:" [X Link](https://x.com/investseekers/status/1977814721228075367) [@investseekers](/creator/x/investseekers) 2025-10-13T19:12Z 4104 followers, 1278 engagements "A calculation error sent $UPST shares tumbling 11%. BTIG had mistakenly reported that XXXX% of loans were delinquent in August the real figure was 6.2%. The correction came Tuesday night after the stock had already plunged. Danish asset manager Horizon3 sees the drop as a buying opportunity but I personally wouldnt invest in Upstart which I explained in my analysis here: #stocks #investing" [X Link](https://x.com/investseekers/status/1975092660101624299) [@investseekers](/creator/x/investseekers) 2025-10-06T06:56Z 4086 followers, 1946 engagements "ChemoMetex ( $CHEMM ) posted strong results in FY 2024/25 despite rising uncertainty. Revenue grew XX% to DKK 496m and EBITDA jumped to DKK 258m from 186m. For FY 2025/26 the company expects revenue of DKK 545565m and EBITDA of DKK 295315m. CEO Martin Helbo Behrens points to rising demand for automation in cell and gene therapy with new XcytoMatic instruments well placed to capture this growth. It remains one of my favourite Danish small caps and I hope to start a position at some point. #stocks #investing" [X Link](https://x.com/investseekers/status/1966375106923397574) [@investseekers](/creator/x/investseekers) 2025-09-12T05:35Z 4085 followers, 1237 engagements "$NVO and Sumitomo Pharma have signed a co-promotion deal for Wegovy in Japan starting November 2025. Under the agreement Novo will handle manufacturing and approval while both companies will jointly promote the obesity treatment to healthcare professionals. The partnership builds on their existing collaboration around Ozempic aiming to expand access to obesity care in Japan where an estimated XX million people live with obesity. #stocks #investing #obesity #Japan" [X Link](https://x.com/investseekers/status/1978333637020942400) [@investseekers](/creator/x/investseekers) 2025-10-15T05:34Z 4108 followers, 5594 engagements "I bought shares in Constellation Software ( $CSU.TO ) yesterday. Heres why: What it does It buys and runs hundreds of small niche software companies things like traffic light systems library software or church administration tools. These products are essential for their customers so very few ever leave. On average a customer stays for about XX years. Around half of its revenue comes from government clients which makes the cash flow stable and predictable. What makes it different It gives founders a permanent home for their businesses instead of buying and reselling them. The company is" [X Link](https://x.com/investseekers/status/1975503366579986763) [@investseekers](/creator/x/investseekers) 2025-10-07T10:08Z 4104 followers, 2144 engagements "$FAST reports earnings tomorrow. It may not sound like the most exciting business with its bolts nuts screws and washers but its surprisingly profitable. Heres why this quiet industrial distributor keeps delivering: #stocks #investing" [X Link](https://x.com/investseekers/status/1977453717512245417) [@investseekers](/creator/x/investseekers) 2025-10-12T19:18Z 4087 followers, 1065 engagements "Swiss pharma giant Roche has spent recent years building a portfolio of weight-loss drugs to capture a share of the booming obesity market dominated by $NVO and $LLY. We now have to deliver on that portfolio said Manu Chakravarthy Roches head of metabolic disease in an interview with Finans. Roche has invested around $6.5B in biotech partnerships focused on obesity diabetes and related diseases a figure that could reach $14B as milestones are met. One major deal is with $ZEAL where Roche paid $1.65B upfront (up to $5.3B total) for rights to its promising obesity drug petrelintide. Link to" [X Link](https://x.com/investseekers/status/1978829912678002705) [@investseekers](/creator/x/investseekers) 2025-10-16T14:26Z 4108 followers, 2005 engagements "$TEP.PA reports earnings Thursday. Some fear #AI disruption but management sees it as a tailwind. If theyre right the stock seems cheap. Full analysis here: #stocks #investing" [X Link](https://x.com/investseekers/status/1950643560442712488) [@investseekers](/creator/x/investseekers) 2025-07-30T19:44Z 4105 followers, XXX engagements "$ZEAL gains Thursday possibly lifted by Novo Nordisks comments on its amylin drug cagrilintide. $NVO said the therapy could serve patients needing moderate weight loss or weight maintenance. Jyske Bank notes this may have boosted sentiment for Zealand which is developing its own amylin drug with Roche. I own a small position in Zealand Pharma" [X Link](https://x.com/investseekers/status/1968673740004188381) [@investseekers](/creator/x/investseekers) 2025-09-18T13:49Z 4108 followers, 1133 engagements "$NVO shares are down around X% on the Danish exchange Friday morning following a decline in its U.S. ADRs after hours Thursday. According to Evan David Seigerman from BMO Capital Markets the selloff is overdone. He says GLP-1 drug prices will remain under pressure but Trumps comments only confirm what we already knew. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1979095208705794057) [@investseekers](/creator/x/investseekers) 2025-10-17T08:00Z 4108 followers, 3215 engagements "@ResearchPulse1 To my knowledge it was approved in 2023. It has been marketed since XX February 2024 in Japan:" [X Link](https://x.com/investseekers/status/1978359980173508619) [@investseekers](/creator/x/investseekers) 2025-10-15T07:19Z 4104 followers, XXX engagements "Last week #Prosus repurchased 2285237 $PRX shares at an average price of XXXXX. They have been buying back shares every week since June 2022. #stocks #investing" [X Link](https://x.com/investseekers/status/1957858475414790476) [@investseekers](/creator/x/investseekers) 2025-08-19T17:33Z 4086 followers, XXX engagements "Per Hansen investment economist form Nordnet has a great write-up on lower U.S. drug prices and what it could mean for $NVO. In recent weeks $PFE and $AZN have struck deals with Donald Trump to lower U.S. prices in exchange for avoiding import tariffs by moving production to the U.S. within X years. Markets didnt panic both stocks rose after the announcements showing that lower prices arent necessarily bad news for pharma. For Novo Nordisk the situation could be different: it already produces most of what it sells in the U.S. inside the country giving it a potential advantage. Still investors" [X Link](https://x.com/investseekers/status/1977611239636209767) [@investseekers](/creator/x/investseekers) 2025-10-13T05:43Z 4108 followers, 4144 engagements "Rothschild & Co Redburn raises its price target on $NVO to DKK XXX from DKK XXX maintaining a Buy rating. #stocks #investing" [X Link](https://x.com/investseekers/status/1979150649066467810) [@investseekers](/creator/x/investseekers) 2025-10-17T11:41Z 4108 followers, 2251 engagements "$NVO shares are down XXX% Tuesday afternoon placing the stock at the bottom of Denmarks C25 index. New industry data suggest the company may be losing GLP-1 market share in Europe to rival $LLY according to $MS. The data based on IQVIA figures through August 2025 indicate Lillys gains are driven by product differentiation and commercial execution rather than supply analysts say. Eli Lilly shares are down XXX% premarket in the U.S. but remain up X% YTD while Novo Nordisk has fallen about 40%. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1978065351196701093) [@investseekers](/creator/x/investseekers) 2025-10-14T11:48Z 4109 followers, 6452 engagements "$NVO just posted a new job opening: Senior Director Medical Affairs Alzheimers Disease based in Copenhagen. The description says they are pushing the boundaries of science with an innovation that could reshape how Alzheimers is understood and treated. Given the timing and wording this could hint that results from the ENVOKE and ENVOKE+ Alzheimers trials might be promising #stocks #investing" [X Link](https://x.com/investseekers/status/1979064707760721952) [@investseekers](/creator/x/investseekers) 2025-10-17T05:59Z 4108 followers, 10.7K engagements "$UBS analysts say Trumps comments on cutting $NVO 's Ozempic prices shouldnt surprise investors potential U.S. price reductions are already factored into their forecasts. If the prices mentioned by President Trump end up being the negotiated prices this would already be captured in our numbers they wrote. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1979121553682956426) [@investseekers](/creator/x/investseekers) 2025-10-17T09:45Z 4108 followers, 2587 engagements "$NVO is entering a difficult phase as the company plans to lay off thousands of employees 5000 in Denmark and 4000 abroad. Experts warn the job cuts could lead to further challenges with up to XX% of remaining staff likely to leave voluntarily due to growing dissatisfaction and uncertainty. New CEO Mike Doustdar now faces the tough task of maintaining morale and retaining key talent amid the restructuring. #stocks #Investing" [X Link](https://x.com/investseekers/status/1975574891660226974) [@investseekers](/creator/x/investseekers) 2025-10-07T14:52Z 4106 followers, 2385 engagements "Terry Smiths Fundsmith recently added $INTU and its easy to see why. Its scale data brand and integrated products create strong network effects and high switching costs. I just updated my analysis: #stocks #Investing" [X Link](https://x.com/investseekers/status/1975646056458158211) [@investseekers](/creator/x/investseekers) 2025-10-07T19:35Z 4097 followers, XXX engagements "The Danish C25 index closed Friday up 0.77%. Winners: Ambu +6.60% Novonesis +2.79% Pandora +2.54% $NVO +2.19% rsted +1.95% Losers: GN Store Nord -XXXX% Coloplast -XXXX% DSV -XXXX% $GMAB -XXXX% Danske Bank -XXXX% #StocksInFocus #investing" [X Link](https://x.com/investseekers/status/1958913091963351549) [@investseekers](/creator/x/investseekers) 2025-08-22T15:24Z 4086 followers, XXX engagements "Want Want #stocks closed down nearly X% today. Its one of Greater Chinas leading food & beverage companies. Best known for its rice crackers milk drinks and snacks loved across generations. Despite the drop the company shows strong fundamentals: Consistent innovation with new products contributing double-digit revenue growth Expanding sales channels through e-commerce and smart vending machines Double-digit overseas growth led by Japan North America & Southeast Asia ROIC above XX% for a decade exceeding XX% in FY2025 A classic example of a steady compounder hiding behind a simple brand. Full" [X Link](https://x.com/investseekers/status/1978025862764060934) [@investseekers](/creator/x/investseekers) 2025-10-14T09:11Z 4109 followers, XXX engagements "According to its latest newsletter Danish investment fund MW Compounders has made $NVO its largest position last quarter. The fund writes that despite Novos weak share performance for three consecutive quarters its fundamental value is far above the current price. The manager used the summer dip to increase the position. He notes Novo has faced issues in the US including compounding pharmacies copying its obesity drugs after earlier supply shortages political pressure on drug costs and some pipeline setbacks. Still he expects improving conditions cost-cutting progress under the new CEO and" [X Link](https://x.com/investseekers/status/1975519849938911426) [@investseekers](/creator/x/investseekers) 2025-10-07T11:13Z 4094 followers, 2612 engagements "I added to my position in $POOL today. Besides $NVO its the only stock in my portfolio thats still negative. #WarrenBuffett has been buying shares recently and for good reason. You can learn more about the company here: #stocks #investing" [X Link](https://x.com/investseekers/status/1976371587143069947) [@investseekers](/creator/x/investseekers) 2025-10-09T19:38Z 4086 followers, 1400 engagements "$NVO is expanding its rare disease portfolio with a new deal to acquire zaltenibart (OMS906) from Omeros a promising treatment for rare blood and kidney disorders. Omeros will get $340M upfront and up to $2.1B in potential milestone payments. Novo plans to start a global phase X trial in paroxysmal nocturnal hemoglobinuria. #stocks #investing" [X Link](https://x.com/investseekers/status/1978442466698146172) [@investseekers](/creator/x/investseekers) 2025-10-15T12:46Z 4104 followers, 3053 engagements "$HSBC has upgraded $NVO to Buy from Hold. Analyst Rajesh Kumar says Novos pipeline is undervalued and not weaker than $LLY s especially after strong data from oral semaglutide and orforglipron. Key 2026 catalysts: REDEFINE4 trial testing CagriSema head-to-head vs Lillys Zepbound EVOKE trial testing oral semaglutide in Alzheimers He also highlights Novos stronger focus on reimbursed and direct-to-consumer channels. #stocks #Investing" [X Link](https://x.com/investseekers/status/1973615049076814187) [@investseekers](/creator/x/investseekers) 2025-10-02T05:04Z 4089 followers, 2129 engagements "#Prosus repurchased another 1479279 shares last week at an average price of XXXXX. The ongoing buyback program continues by selling #Tencent shares to buy back $PRX shares at a discount increasing the Tencent holding per Prosus share. #stocks #Investing" [X Link](https://x.com/investseekers/status/1975627182429872179) [@investseekers](/creator/x/investseekers) 2025-10-07T18:20Z 4107 followers, XXX engagements "The Danish C25 index fell XXX% on Monday. At the bottom were GN Store Nord down XXX% and Vestas down 2.3%. On the positive side $GMAB rose XXX% and A.P. Mller Mrsk gained XXX% while $NVO ended the day down 0.9%. #stocks #investing #Denmark" [X Link](https://x.com/investseekers/status/1977806816756277259) [@investseekers](/creator/x/investseekers) 2025-10-13T18:41Z 4106 followers, 1293 engagements "$GMAB announced that global DARZALEX sales reached $XXXX billion in Q3 2025 according to $JNJ. Sales totaled $2.09B in the U.S. and $1.58B internationally. Genmab earns royalties on worldwide DARZALEX sales under its license agreement with J&J. #stocks #investing" [X Link](https://x.com/investseekers/status/1978047404676202617) [@investseekers](/creator/x/investseekers) 2025-10-14T10:37Z 4100 followers, 1086 engagements "The Danish C25 index fell XXX% Monday dragged down by rsted closing -16.4%. Winners: Zealand Pharma +1.4% $NVO +0.9% $GMAB +0.3% Sydbank +0.2% Losers: rsted -XXXX% GN Store Nord -XXX% Vestas -XXX% Maersk B -XXX% Pandora -XXX% #Stocks #investing" [X Link](https://x.com/investseekers/status/1960014809325244873) [@investseekers](/creator/x/investseekers) 2025-08-25T16:22Z 4086 followers, XXX engagements "CEO of Zealand Pharma did a Q&A on Danish investor site Proinvestor. If youre interested in companies like $NVO or $LLY or just obesity in general its definitely worth a read. Here are my notes: Zealand is stronger than ever: $1.4B upfront payment from Roche unique 50/50 profit split in US & Europe and Roche covers all manufacturing investments. Petrelintide (amylin analog) is the crown jewel. Early data: significant weight loss with fewer GI side effects vs GLP-1s. Could become the foundational therapy for obesity treatment. Phase X results (ZUPREME-1 & 2) due H1 2026. Phase X monotherapy" [X Link](https://x.com/investseekers/status/1960714942505525622) [@investseekers](/creator/x/investseekers) 2025-08-27T14:44Z 4109 followers, 4034 engagements "$RMD is the leader in its sector. But as $NVO and $LLY obesity drugs gain more traction will demand for ResMeds products shrink I just updated my analysis: #Stocks #investingtips" [X Link](https://x.com/investseekers/status/1964206520641479056) [@investseekers](/creator/x/investseekers) 2025-09-06T05:58Z 4104 followers, 1016 engagements "$DIA.MI is trading near a 52-week low and at its highest free cash flow yield in a decade. In case you don't know DiaSorin: it is a focused diagnostics company based in Italy that develops both lab instruments and test kits used to diagnose a wide range of medical conditions. The company specializes in in vitro diagnostics meaning tests performed in laboratories on blood tissue and other biological samples. It concentrates on areas such as infectious diseases hormone disorders autoimmune conditions and oncology. This specialized focus has enabled DiaSorin to build deep scientific expertise" [X Link](https://x.com/investseekers/status/1941116156544213301) [@investseekers](/creator/x/investseekers) 2025-07-04T12:45Z 4107 followers, XXX engagements "Jyske Bank says $NVO s $4.7B acquisition of $AKRO its largest R&D deal ever strengthens its pipeline in MASH a severe liver disease with no approved treatments. While the market initially reacted negatively due to uncertainty around MASH and higher near-term R&D costs Jyske Bank calls the deal overall positive. Novo gains rights to Efruxifermin seen as a potential first- and best-in-class treatment for advanced (F4) MASH possibly used alone or with Wegovy which already targets earlier MASH stages. With an estimated 250M people globally affected the unmet need is huge. Rival pharma giants" [X Link](https://x.com/investseekers/status/1976552114001150197) [@investseekers](/creator/x/investseekers) 2025-10-10T07:35Z 4107 followers, 2619 engagements "$AHT.L reports Wednesday. Best known as Sunbelt Rentals its a market leader in equipment rental and market leaders often compound for decades. My analysis: #Stocks #investing" [X Link](https://x.com/investseekers/status/1962882203471274434) [@investseekers](/creator/x/investseekers) 2025-09-02T14:16Z 4101 followers, XXX engagements "$NVO continues to be one of the best opportunities in the market" [X Link](https://x.com/investseekers/status/1977381335149748560) [@investseekers](/creator/x/investseekers) 2025-10-12T14:30Z 4107 followers, 33.3K engagements "$OXM reports earnings tonight. It owns Tommy Bahama Lilly Pulitzer & Johnny Was with pricing power loyal customers and strong DTC execution. Yet the stock is down nearly XX% this year. My full analysis here: #stocks #investing" [X Link](https://x.com/investseekers/status/1965862591890141650) [@investseekers](/creator/x/investseekers) 2025-09-10T19:39Z 4107 followers, XXX engagements "Its interesting because both the CEO of Zealand Pharma and the CFO of Novo Nordisk have said they expect the vast majority to stick with injections at least until 2030. But that is probably among people with obesity while those looking to lose weight for aesthetic reasons will likely prefer the pill. But youre the expert not me 😀" [X Link](https://x.com/investseekers/status/1979150423484248485) [@investseekers](/creator/x/investseekers) 2025-10-17T11:40Z 4106 followers, XXX engagements "Denmarks C25 index rose XXX% Monday led by rsted (+3.5%) after reports Equinor is ready to buy shares worth billions. $NVO gained as new data showed Wegovy outperforms $LLY's Zepbound on cardiovascular risk reduction while Zealand Pharma climbed XXX% and $GMAB XXX% #StocksInFocus #investing" [X Link](https://x.com/investseekers/status/1962536764641288508) [@investseekers](/creator/x/investseekers) 2025-09-01T15:23Z 4109 followers, 1412 engagements "$GMAB will get news from the U.S. today as its partner $JNJ reports Q3 earnings. The results will include new sales figures for Darzalex the blockbuster cancer treatment co-developed by Genmab. J&J holds the marketing rights and pays royalties to Genmab. Genmab last raised its 2025 Darzalex sales forecast to $13.714.1 billion. #stocks #investing" [X Link](https://x.com/investseekers/status/1978020200361406530) [@investseekers](/creator/x/investseekers) 2025-10-14T08:49Z 4108 followers, 1239 engagements "$TEP.PA dropped over XX% today after unveiling its Future Forward strategy. Investors are uneasy about the near-term costs and payoff timeline. Is it a buying opportunity Read the full analysis here: #StocksInFocus #investing" [X Link](https://x.com/investseekers/status/1935402131667747276) [@investseekers](/creator/x/investseekers) 2025-06-18T18:20Z 4105 followers, XXX engagements "Zacks featured $LLY $NVO $AMGN and $VKTX in its latest analyst blog. Eli Lilly reports Q3 earnings on Oct XX and all eyes are on its GLP-1 blockbusters. Analysts estimate Mounjaro sales at $5.3B and Zepbound at $3.5B. $GS expects the U.S. obesity market to reach $100B by 2030. Lilly and Novo Nordisk dominate but Amgen (MariTide) and Viking Therapeutics (VK2735) are emerging challengers. Zacks rates Eli Lilly a Hold strong growth momentum but a premium valuation at XX forward earnings. #StocksToWatch #investing" [X Link](https://x.com/investseekers/status/1979212559187157004) [@investseekers](/creator/x/investseekers) 2025-10-17T15:47Z 4108 followers, 1336 engagements "Short interest in major Danish stocks: GN Store Nord: XXX% (most shorted stock in Denmark) $ZEAL: XXX% (shorts declining) Vestas: XXX% Mrsk: XXX% Pandora: XXX% rsted: XXX% Novonesis: XXX% $GMAB: XXX% $NVO: XXX% #stocks #Investing" [X Link](https://x.com/investseekers/status/1974003432731107350) [@investseekers](/creator/x/investseekers) 2025-10-03T06:47Z 4107 followers, 1864 engagements "Cathie Woods ARK Invest keeps buying $BABA adding over 4000 shares to its flagship $ARKK ETF last week. That brings ARKKs total exposure to about $XX million as ARK continues its steady accumulation of the Chinese tech giant. #stocks #investing" [X Link](https://x.com/investseekers/status/1977678825736622276) [@investseekers](/creator/x/investseekers) 2025-10-13T10:12Z 4104 followers, 1256 engagements "$NVO shares are falling sharply on Friday after U.S. President #DonaldTrump once again demands lower prices for weight-loss drugs. According to Sydbanks senior analyst Sren Lntoft Hansen investors are focusing only on the negatives but potential deals with the Trump administration could also create opportunities. He points to $PFE s agreement to lower prices for Medicaid patients in exchange for three years of tariff exemptions as an example. Trump specifically mentions Ozempic which shares the same active ingredient as Wegovy saying prices will be much lower. Novo is already in price" [X Link](https://x.com/investseekers/status/1979171035527221440) [@investseekers](/creator/x/investseekers) 2025-10-17T13:02Z 4108 followers, 2946 engagements "Health investor Claus Henrik Johansen (CEO Global Health Invest) calls $GMAB s $8B acquisition of Merus 'extremely positive.' He says the $8B is well spent and strengthens the long-term case giving Genmab a new pipeline to build on toward the end of this decade and into the next. Cancer is a field where acquisitions are a natural way to add products and Merus lead drug could secure Genmab a strong position in head & neck cancer a hard-to-treat disease where even small improvements can be globally significant. If it also proves effective in colorectal cancer the potential is even greater. He" [X Link](https://x.com/investseekers/status/1973075996845961255) [@investseekers](/creator/x/investseekers) 2025-09-30T17:22Z 4100 followers, 1070 engagements "$NVO shares are regaining momentum this week after positive newsflow from the EASD diabetes congress. New real-world data showed Ozempic reduced the risk of heart attack stroke & death by XX% vs $LLY s Trulicity. That helped boost sentiment which Jyske Bank analyst Henrik Hallengreen Laustsen says seems to be slowly turning after a difficult year with too many negative surprises. Deutsche Bank added that Wegovy in pill form is still expected to play an important role across both diabetes & obesity. Berenberg also upgraded Novo to Buy this week. Danske Bank analyst Lars Skovgaard Andersen" [X Link](https://x.com/investseekers/status/1968649274092061181) [@investseekers](/creator/x/investseekers) 2025-09-18T12:12Z 4108 followers, 1622 engagements "The Danish C25 index closed slightly higher on Friday ending the week up 0.4%. Jyske Banks late earnings upgrade on Thursday sparked a rally among Danish banks which dominated the top of the index while $NVO ended the day down 0.75%. #stocks #investing #Denmark" [X Link](https://x.com/investseekers/status/1976701780638810283) [@investseekers](/creator/x/investseekers) 2025-10-10T17:30Z 4109 followers, 1210 engagements "$RI.PA is down XX% from 2023 highs as health trends GLP-1 drugs & new rivals weigh on alcohol stocks. #WarrenBuffett is buying into the sector. I just updated my analysis: #stocks #investing #alcohol" [X Link](https://x.com/investseekers/status/1967308997079212538) [@investseekers](/creator/x/investseekers) 2025-09-14T19:26Z 4097 followers, 1681 engagements "$RBREW reports earnings Tuesday. The Nordic & Baltic beverage leader has built its strength on local brands + partnerships with $PEP & Heineken. Read my full analysis here: #Stocks #investing" [X Link](https://x.com/investseekers/status/1959999709797286224) [@investseekers](/creator/x/investseekers) 2025-08-25T15:22Z 4086 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@investseekers Investseekers
Investseekers posts on X about $nvo, stocks, novo, $lly the most. They currently have XXXXX followers and 1337 posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXXX +80%
- X Month XXXXXXX +7.90%
- X Months XXXXXXXXX +158%
- X Year XXXXXXXXX +12,778%
Mentions: XXX #
- X Week XXX +24%
- X Month XXX -XXXX%
- X Months XXXXX +62%
- X Year XXXXX +805%
Followers: XXXXX #
- X Week XXXXX +3.10%
- X Month XXXXX +17%
- X Months XXXXX +134%
- X Year XXXXX +1,296%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks #3376 finance #3988 currencies #2602 countries XXXX% cryptocurrencies XXX% technology brands XXXX% travel destinations XXXX% luxury brands XXXX% celebrities XXXX% exchanges XXXX%
Social topic influence $nvo #7, stocks #958, novo #198, $lly #16, $gmab #2, acquisition #957, denmark #515, longterm #284, nvo #4, over the XXXX%
Top accounts mentioned or mentioned by @hl3133 @gusatlantis @fiinvest2030 @exclamotite69 @tacticzh @1daveline @boriszr @xstryx @tonymacarroni91 @damianofomo @marcom41184621 @tihobrkan @jacobcordosa @theeuinvestor @valuez6912 @markedsbrok @baselinex2024 @dywidendowopl @aretardinvestor @teechongyen
Top assets mentioned Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) Copart, Inc. (CPRT) Alibaba Group (BABA) Pfizer, Inc. (PFE) Watsco, Inc. (WSO) JPMorgan Chase (JPM) Parex (PRX) PoolTogether (POOL) Zoetis Inc (ZTS) Barclays PLC (BCS) PepsiCo, Inc. (PEP) Hims & Hers Health, Inc. (HIMS) AstraZeneca PLC (AZN) Morgan Stanley (MS) HSBC Holdings PLC (HSBC) Deutsche Bank Aktiengesellschaft (DB) Akropolis (AKRO) Scholar Rock Holding Corporation Common Stock (SRRK) Regeneron Pharmaceuticals Inc (REGN) Synthetify (SNY) Otis Worldwide Corp (OTIS) Diageo plc (DEO) AbbVie Inc (ABBV) Sanofi (SNY)
Top Social Posts #
Top posts by engagements in the last XX hours
"@ftr_investors Revenue not below 2025 Haha $ASML really feels like the semiconductor version of $NVO absolute market leader but management is way too modest when presenting results/growth. Guess its just our European way of doing things 😄"
X Link @investseekers 2025-10-15T06:37Z 4087 followers, XXX engagements
"Spanish drugmaker Rovi will start producing medicines for $NVO from 2026 according to elEconomista. Rovi will manufacture pre-filled syringes likely for Novos blockbuster Ozempic and Wegovy at its Madrid facility under a five-year contract worth an estimated 82184 million annually starting in 2027. #stocks #investingtips"
X Link @investseekers 2025-10-13T12:56Z 4105 followers, 2773 engagements
"A rough day on the Danish stock market. The C25 index fell XXX% on Tuesday pressured by declines in $NVO and green #stocks . Novo Nordisk dropped XXX% marking its fourth straight day of losses. rsted and Vestas fell XXX% and XXX% respectively while Mrsk topped the index with a XXX% gain. #investing #Denmark"
X Link @investseekers 2025-10-14T15:48Z 4086 followers, 1364 engagements
"Berenberg warns the 30-year luxury boom may be over citing a structural demand problem driven by Chinas slowdown and changing spending habits among young consumers. The bank downgraded #LVMH to Hold and Kering to Sell saying luxury stands at a crossroads. I disagree. People have craved luxury for millennia from gold and jewels in ancient civilizations to designer goods today. With the middle class expanding in emerging markets I doubt we are seeing structural demand problems. I currently only hold LVMH but could add Richemont at the right price and certainly also Herms which is a tier above"
X Link @investseekers 2025-10-16T12:49Z 4106 followers, 1117 engagements
"#WarrenBuffett more than doubled his stake in $POOL again this quarter. Its a quality business at a reasonable price and I own it too. Heres why this company deserves a closer look: #stocks #investing"
X Link @investseekers 2025-08-14T20:13Z 4103 followers, XXX engagements
"Zoetis ( $ZTS ) The human-animal bond is a powerful long-term driver for Zoetis. Pet owners today are younger wealthier and more committed to their pets health than ever before. Millennials and Gen Z are delaying kids but spending more on pets a secular trend boosting demand for veterinary care. Zoetis expects the animal health market to grow from $45B to $80B by 2032 driven by longer pet lifespans and chronic conditions like osteoarthritis and allergies. Its blockbuster drugs Librela Solensia and Simparica Trio show how powerful this trend already is. The livestock segment adds"
X Link @investseekers 2025-10-11T10:54Z 4094 followers, XXX engagements
"$GMAB s partner $JNJ reports positive phase X results from the Majestec-3 study combining Tecvayli and Darzalex Faspro. The combo showed significantly improved survival rates and longer time without disease progression compared to current standard treatments. Genmab earns royalties of 1220% on Darzalex sales and mid-single-digit royalties on Tecvayli. #StocksToWatch #investing"
X Link @investseekers 2025-10-16T13:50Z 4106 followers, 1054 engagements
"I just read through $GMAB 's earnings call transcript and here are my notes Commitments & Progress In 2025 Genmab set three main goals: 1) Speed up development of its most important late-stage drugs. 2) Grow sales of already-approved medicines. 3) Allocate capital in ways that support long-term growth. In the first half of 2025: revenue rose XX% operating profit rose XX% and the company continued heavy investment in key programs. Cash on hand: about $3B giving flexibility for expansion. Main Growth Drivers Three drugs expected to generate major revenue by the end of the decade:Epcoritamab"
X Link @investseekers 2025-08-09T10:06Z 4108 followers, 2944 engagements
"The Danish C25 index closed up XXX% on Thursday. $GMAB rose XXX% after partner $JNJ reported improved survival rates in a combo cancer study with Tecvayli and Darzalex Faspro. $NVO gained XXX% as BNP Paribas Exane raised its price target to DKK XXX (from 345) while Handelsbanken cut its target to DKK XXX (from 525). #StocksToWatch #investing #Denmark"
X Link @investseekers 2025-10-16T16:32Z 4104 followers, 1457 engagements
"The FDA has deemed $NVO s newly acquired Indiana plant out of compliance a serious designation that could delay drug approvals for partners like $SRRK and $REGN. Issues reportedly included cat hair pests and equipment failures. Novo says fixing them is a top priority. #stocks #investing"
X Link @investseekers 2025-10-14T06:57Z 4108 followers, 2654 engagements
"With #Trump tariffs tanking the #StockMarket yesterday there are especially X US stocks that look interesting to me right now: $ZTS $WSO and $CPRT. If you are looking for something to research over the weekend these three are worth your time"
X Link @investseekers 2025-10-11T10:54Z 4091 followers, 1381 engagements
"The Danish C25 index rose XXX% on Wednesday after two days of declines. $NVO recovered from early losses to close XXX% higher at DKK XXXXXX after announcing the acquisition of assets and a license for a clinical-stage drug targeting rare blood and kidney diseases. NKT led the index rising 3.6%. #stocks #investing"
X Link @investseekers 2025-10-15T20:37Z 4104 followers, 1311 engagements
"$BCS has turned more positive on European healthcare stocks upgrading the sector to overweight. This could benefit major European pharma names such as $NVO Roche and $SNY which dominate the regions healthcare benchmarks. The banks strategists led by Emmanuel Cau say reduced uncertainty around drug pricing a more stable euro/dollar and cheap valuations make the sector attractive again. They highlight that healthcare is starting to recover as the euro stabilizes and U.S. demand picks up. Investor positioning which had been weak is also showing early signs of improvement. #stocks #Investing"
X Link @investseekers 2025-10-08T12:42Z 4090 followers, 1155 engagements
"Private equity owners are preparing a 2026 IPO for TK Elevator. I like the elevator sector there are no alternatives service is required by law and urbanization means taller buildings. I own KONE and want to buy $OTIS at the right price too. #Stocks #investing"
X Link @investseekers 2025-09-08T18:30Z 4096 followers, XXX engagements
"Royal Unibrew ( $RBREW ) just posted strong H1 results Volumes +4% despite cold weather in Finland (offset by strong July & Western Europe) Net revenue +3% boosted by new $PEP partnership in Belgium/Luxembourg EBIT +11% with XX bps margin expansion (better efficiency & execution) EPS +18% Very strong performance in Italy France & International segment Market share gains across most geographies New DKK 300m buyback launched 2025 guidance narrowed: XX% revenue growth XXX% EBIT growth Management says these results highlight the strength of its multi-beverage model geographic diversity and"
X Link @investseekers 2025-08-26T16:50Z 4108 followers, XXX engagements
"$JPM analyst Richard Vosser maintains a Buy rating on $NVO with a target price of DKK XXX. #stocks #investing"
X Link @investseekers 2025-10-06T16:49Z 4095 followers, 1952 engagements
"BNP Paribas Exane has raised its price target for $NVO to DKK XXX from DKK XXX while maintaining a neutral rating on the stock. #StocksToWatch #investing"
X Link @investseekers 2025-10-16T07:15Z 4104 followers, 1579 engagements
"Just published: my analysis of $ASH.L Ashtead is one of the worlds largest equipment rental firms. Its dense branch network & metro-area clusters boost efficiency cut delivery times & give it an edge over smaller rivals. Read it here: #stocks #invest"
X Link @investseekers 2025-08-16T06:01Z 4109 followers, XXX engagements
"@StenAndersen13 @seep2p It would be illegal for Novo Nordisk not to disclose the data if they already had it. That said they might have preliminary indications or trends from the EVOKE/EVOKE+ trials but not the full validated results yet"
X Link @investseekers 2025-10-17T06:46Z 4106 followers, XXX engagements
"#WarrenBuffett emphasizes that integrity is the most critical quality in management believing that a lack of it is disastrous even in intelligent and energetic individuals. I don't think I could ever invest in $HIMS"
X Link @investseekers 2025-10-17T08:36Z 4108 followers, 3359 engagements
"#LeBronJames and Hennessy just launched a limited-edition Hennessy V.S.O.P bottle designed with LeBron available in select markets this month. Hennessy is part of Mot Hennessy owned XX% by $MC.PA and XX% by $DEO. Both #LVMH and Diageo shares are up today. #stocks #Investing"
X Link @investseekers 2025-10-07T17:19Z 4101 followers, XXX engagements
"Sweden has produced some exceptional serial acquirers that have delivered strong long-term returns for shareholders. One of the best is $ADDT. I just published my full analysis of the company read it here: #StocksToWatch #investing"
X Link @investseekers 2025-10-18T05:43Z 4108 followers, XXX engagements
"$TEP.PA has dropped from XXX to under XXX on AI fears but the company sees AI as a long-term tailwind not a threat. Full analysis here: #StocksToWatch #InvestingTips"
X Link @investseekers 2025-06-12T05:07Z 4105 followers, XXX engagements
"Novo Nordisk is down over XX% year-on-yearbut Jyske Bank calls it a golden buying opportunity. Despite short-term uncertainty the bank says $NVO has some of the sectors most attractive growth prospects with expected annual sales growth of XX% through 2027 (vs. X% for the sector). Novo now trades at half the valuation of $LLY even though they were similarly priced a year ago. Jyskes price target DKK 850implying more than XXX% upside. #StocksToBuy #Investing"
X Link @investseekers 2025-04-23T16:23Z 4086 followers, 10.8K engagements
"$NVO has hired $ABBV 's Greg Miley as its new SVP of Corporate Affairs. Greg Miley a pharma veteran with nearly XX years of experience in government and public affairs previously led global policy and legislative strategy at AbbVie and held senior roles at Sanofi and Pfizer. He is also a board member of the Public Affairs Council and has extensive experience navigating U.S. healthcare policy and drug pricing debates which will be valuable given Novos current challenges in the U.S. market. He will relocate to Denmark to lead Novo Nordisks global communications and public affairs. Hopefully"
X Link @investseekers 2025-10-17T18:16Z 4108 followers, 2270 engagements
"I just did a quick back-of-the-envelope calculation: #Prosus owns 2091.4M #TENCENT shares. With Tencent closing at XXXXXX HKD thats worth about 155.5B. Divided by Prosuss 2.19B shares outstanding = XXXX per share in Tencent value. Prosus trades at XXXX meaning you are getting Tencent at a discount and everything else Prosus owns for free. Prosus remains my largest position. #stocks #investing"
X Link @investseekers 2025-10-09T09:08Z 4107 followers, XXX engagements
"The Danish C25 index fell XXX% on Thursday. $NVO made headlines after announcing the $XXX billion acquisition of U.S. biotech Akero Therapeutics its largest R&D deal ever. The market reaction was muted with Novo Nordisk shares ending the day down 1.3%. Meanwhile Maersk shares declined as progress in Middle East peace talks weighed on shipping stocks. #stocks #investing #Denmark"
X Link @investseekers 2025-10-09T16:28Z 4091 followers, 1384 engagements
"The Danish C25 index managed to turn green after spending most of the day in red finishing up +0.14%. Todays winners: GN Store Nord +19.9% NKT +3.3% $NVO +3.0% $GMAB +2.0% Vestas +1.5% Todays losers: Novonesis -XXX% Coloplast -XXX% Nordea -XXX% DSV -XXX% Royal Unibrew -XXX% #stocks #investing"
X Link @investseekers 2025-08-21T17:15Z 4086 followers, XXX engagements
"Financial Times dives into what it calls $NVO s lottery ticket the Danish drugmakers upcoming Alzheimers trials using its blockbuster semaglutide (Wegovy/Ozempic). Two large phase X studies testing the drug in thousands of early-stage patients could reveal whether GLP-1s can slow or even alter the disease a potential breakthrough for the 55M people living with dementia. Novo execs describe the trials as high-risk high-reward. After the stocks XX% drop over the past year positive data could be transformative. Some studies already suggest semaglutide users have a XX% lower dementia risk"
X Link @investseekers 2025-10-15T06:40Z 4108 followers, 14.3K engagements
"Euroinvestor looked at analyst targets for Denmarks C25 stocks. The X with the highest upside over the next XX months: X Zealand Pharma +67% X Ambu +44% X DSV +40% X Demant +34% X GN Store Nord +32% $ZEAL tops the list despite falling XX% in the past year. I own a small position in Zealand Pharma none of the others. Link to article (in Danish): #stocks #investing #Denmark"
X Link @investseekers 2025-10-01T05:28Z 4104 followers, XXX engagements
"The sharp share price drop in $NVO this year is a clear overreaction according to Danish wealth manager Formue & Investeringspleje. They note that Novo is trading at a forward P/E of XX compared to XXXX for the global index arguing the market is undervaluing Novos long-term growth in obesity treatments. #stocks #investing"
X Link @investseekers 2025-10-14T07:59Z 4101 followers, 2837 engagements
"$MORN just asked the big question: is it time to buy Danish stocks The Morningstar Denmark Index is the worst-performing index globally in 2025 down XXXX% YTD and XXXX% in XX months. Key drivers: $NVO with a XX% index weight is down nearly XX% in a year dragging the entire market lower. Orsted and Vestas slumped as green energy faces falling prices nuclear competition and US policy headwinds. Orsted shares are -XX% YoY after an 8.1B rights issue and a US stop-work order on Revolution Wind. US-Denmark tensions add risk with Trumps revived push to buy Greenland raising speculation around US"
X Link @investseekers 2025-09-19T04:43Z 4106 followers, 1814 engagements
"#Carlsberg now expects 110m in synergies from its 29bn Britvic acquisition up from 100m. CEO Jacob Aarup-Andersen says that after 8+ months of integration nothing unexpected has surfaced and more staff overlaps mean bigger cost savings. I believe $CARLB trades at an attractive valuation but is it enough to buy I wrote more here: #stocks #investing #beer"
X Link @investseekers 2025-10-01T12:14Z 4085 followers, XXX engagements
"#Prosus repurchased 1264403 $PRX shares last week at an average price of XXXXX per share. The company has been buying back shares every week since June 2022. It remains my largest position ahead of $NVO and $BABA. #stocks #investing"
X Link @investseekers 2025-10-15T08:41Z 4109 followers, 1467 engagements
"Danish financial media outlet konomisk Ugebrev has written an excellent deep dive on $PFE s $70/share acquisition of U.S. obesity biotech Metsera revealing just how intense the bidding war was. According to Metseras SEC filing six major pharma companies - including Pfizer and likely rivals such as $NVO or $LLY - were involved. Pfizer ultimately secured the deal with an offer of $XXXXX in cash plus $XXXXX in milestone payments narrowly beating a rival bid of $87/share that fell apart due to regulatory hurdles. Metseras amylin-based obesity candidates (MET-097i and MET-233i) have significant"
X Link @investseekers 2025-10-17T10:57Z 4108 followers, 1325 engagements
"Theres plenty of upside potential in Danish large-cap #stocks at least according to analyst estimates compiled by Euroinvestor from Bloomberg data. Analysts top pick is Zealand Pharma whose average price target suggests +54% upside despite the stock being down over XX% this year. Other C25 stocks with strong potential include: DSV +33% Ambu +29% Pandora +29% GN Store Nord +26% Carlsberg +24% Demant +23% Rockwool +22% Coloplast +20% Novonesis +19% Link to article (in Danish): #StocksToWatch #investing #Denmark"
X Link @investseekers 2025-10-16T11:24Z 4100 followers, XXX engagements
"I just read through the earnings call transcript of #LVMH and here are my notes: Growth in Q3 LVMH returned to organic growth up X% in Q3 (4% reported after a X% FX hit). All other divisions also grew organically with Selective Retailing (Sephora) standing out. Regional trends Mainland Chinas local sales returned to growth while total spending by Chinese consumers (local + tourist) was still slightly negative but improving. The U.S. improved sequentially from Q2. Japan rebounded after tough comps. Europe was broadly stable but slightly impacted by softer tourism. Southeast Asia remained weak"
X Link @investseekers 2025-10-16T06:19Z 4109 followers, 1372 engagements
"Yesterday news broke that $NVO is ending its work and research in cell therapy. It is a bold move under new CEO Mike Doustdar who has repeatedly said Novo should focus on its core in diabetes obesity and cardiovascular disease. Former CEO Lars Fruergaard Jrgensen once called cell therapy a decisive project for Novo noting the company had worked on it for XX years. Mike Doustdars decision marks a clear shift from pursuing every opportunity to doubling down on what works. It is early days but Novo now appears leaner more focused and more pragmatic under his leadership. #stocks #investing"
X Link @investseekers 2025-10-11T16:38Z 4100 followers, 6829 engagements
"$NVO is rewarded by investors after Wegovy was approved in the US for treating fatty liver disease (MASH). According to Nordnets Per Hansen the positive sentiment could also spill over to $ZEAL . Zealand Pharma together with its partner Boehringer Ingelheim initiated two Phase X studies in October 2024 to test their drug candidate Survodutide against MASH. The trials are designed to run for XX weeks with results expected in the first half of 2026. Fatty liver (MASH) has long been a key focus for Zealand Pharma and the company has previously stated hopes that Survodutide could become a"
X Link @investseekers 2025-08-18T07:21Z 4108 followers, 2463 engagements
"#prosus just unveiled the Large Commerce Model an AI system built to rethink how ecommerce works. Instead of using traditional search and recommendation engines The Large Commerce Model understands what people are looking for and why. Its trained on data from over XXX million users and XX trillion data points constantly learning to make online shopping more personal and intuitive. The model is already showing results across Prosuss global portfolio including iFood OLX eMag and Despegar with: X higher click-through rates on notifications XX% boost in personalised recommendations XXX% lift in"
X Link @investseekers 2025-10-10T08:45Z 4107 followers, 1184 engagements
"$NVO CEO Mike Doustdar tells Danish business daily Brsen about the companys acquisition of Akero Therapeutics: We believe efruxifermin could become a cornerstone therapy alone or together with Wegovy to tackle one of the fastest-growing metabolic diseases of our time. #stocks #investing"
X Link @investseekers 2025-10-09T11:03Z 4091 followers, 2835 engagements
"@JacobCordosa Lets see. Premarket $NVO and $LLY are down roughly the same"
X Link @investseekers 2025-10-17T12:10Z 4109 followers, XXX engagements
"A professional jury has named Novo Nordisk Foundation and Novo Holdings the controlling owners of $NVO leaders Kasim Kutay Mads Krogsgaard Thomsen and Lars Rebien Srensen as Denmarks Business Profiles of the Year 2025. The award recognizes their leadership behind major contributions to Danish business and society including Novo Holdings acquisition of Catalent support for the NovozymesChr. Hansen merger that created Novonesis and the Foundations record funding for research and sustainability. Kutay has transformed Novo Holdings with record returns and a growing focus on green investments."
X Link @investseekers 2025-10-10T05:34Z 4094 followers, 2795 engagements
"According to Danish newspaper Brsen $NVO was reportedly one of the bidders for biotech firm Metsera which was ultimately acquired by $PFE in September for $XXX billion. Documents from Metsera show that two companies offered more than Pfizer yet Pfizer still won the deal. Analysts at BMO Capital Markets believe Novo Nordisk was likely Party X one of the losing bidders given its dominant position in the GLP-1 and amylin markets and the timing of the talks shortly after CagriSemas disappointing data in December 2024. According to the documents Novo reportedly bid $X billion in cash in January"
X Link @investseekers 2025-10-08T09:22Z 4101 followers, 3015 engagements
"The Gates Foundation and Pan American Health Organization (PAHO) are exploring ways to make weight-loss drugs like $NVO s Wegovy and $LLY s Mounjaro more accessible in low-income countries Reuters reports. Bill Gates said his foundation aims to take drugs proven in rich countries and make them super super cheap so they can reach everyone. PAHO chief Dr. Jarbas Barbosa added that the organization is preparing usage guidelines and plans to meet with Novo Nordisk Lilly and generic makers in the coming weeks to discuss broader access. #stocks #investing"
X Link @investseekers 2025-10-10T09:16Z 4091 followers, 2659 engagements
"$NVO just lost its lawsuit against the US government over Medicare drug price negotiations marking the 15th straight court defeat for Big Pharma. A federal appeals court rejected Novos claims that the program violates the Constitution siding with earlier rulings against $AZN and $BMY. The news may help explain why Novo shares are down today. Starting in 2026 Medicare will negotiate lower prices on its first batch of drugs expected to save patients $1.5B and taxpayers $6B in the first year. Full story: #stocks #Investing"
X Link @investseekers 2025-10-07T07:42Z 4106 followers, 2469 engagements
"BMO Capital Markets has raised its price target for $NVO s U.S.-listed ADR to $XX ( DKK 355.44) from $XX while maintaining a market perform rating. The new target is about XXX% below Novos current U.S. share price of $XXXXX. #stocks #investing"
X Link @investseekers 2025-10-14T09:44Z 4100 followers, 1669 engagements
"Should you buy $NVO right now Analysts are split: Morgan Stanley cut it to underweight while HSBC upgraded it to buy. With oral Wegovy awaiting FDA approval and Alzheimers data coming in 202526 Novo might appeal to speculative investors looking for upside. Link to article: #stocks #investing"
X Link @investseekers 2025-10-12T17:31Z 4107 followers, 4317 engagements
"Where do analysts see the biggest upside among Danish large caps According to Bloomberg data compiled by Euroinvestor analysts believe several C25 #stocks are trading far below fair value with five names standing out for their potential double-digit gains: X Zealand Pharma top pick seen rising XX% over the next year as analysts target DKK XXXXX vs. Fridays XXXXX. X DSV logistics giant with XX% upside after a weak year. X Pandora analysts see XX% upside despite a XX% drop YTD. X Ambu medical device maker with XX% potential. X Demant hearing aid group seen climbing 29%. Overall analysts expect"
X Link @investseekers 2025-10-13T09:11Z 4109 followers, 1190 engagements
"Jumbo Interactive ( $JIN ) jumps +8% after announcing its entry into the UK prize draw market with the acquisition of Dream Car Giveaways a leading B2C platform offering car cash and lifestyle prizes. The deal worth A$109.9M marks Jumbos biggest step yet in expanding internationally. DCG generated A$118M in TTV and A$17.9M in revenue over the past year and the acquisition is expected to be EPS accretive within XX months. With a 6.5x EBITDA multiple and 2025% EBITDA growth expected the deal looks like a strong strategic move and despite todays jump the shares still look cheap. Read my full"
X Link @investseekers 2025-10-15T07:40Z 4100 followers, XXX engagements
"$DB has raised its price target on $GMAB by X% to DKK 2000 from DKK 1900 while maintaining a Buy rating. Despite the upgrade the new target sits slightly below Fridays closing price of DKK 2100 implying limited near-term upside. Genmabs shares are up XX% in 2025 and nearly XX% since Aprils low boosted by this weeks DKK 51B acquisition of Dutch biotech Merus which alone sent the stock up 14%. Deutsche Bank has rated the stock Buy since November 2023 when it traded around DKK 2153. #stocks #investing"
X Link @investseekers 2025-10-06T06:08Z 4100 followers, 1072 engagements
"$BCS has upgraded $ROCKB to Overweight from Equal Weight and raised its price target by DKK XX to DKK XXX implying XX% upside. I dont own Rockwool but its on my watch list. Energy efficiency is one of the strongest structural growth drivers for the company. Buildings account for nearly one-third of global energy use and CO emissions and insulation is among the most cost-effective ways to reduce both. Rockwools stone wool insulation can cut heating needs by up to 70%. With the EUs new Energy Performance of Buildings Directive and rising global efficiency standards Rockwool is well positioned"
X Link @investseekers 2025-10-09T08:36Z 4104 followers, XXX engagements
"I still agree that $NVO is one of the best deals in the market"
X Link @investseekers 2025-10-14T19:24Z 4101 followers, 8293 engagements
"Danish financial outlet konomisk Ugebrev writes about $NVO s latest move in the obesity market. Novo shares rose X% yesterday after the company outlined plans to launch its upcoming weight-loss pill in the US through telehealth platforms once FDA approval arrives (expected H1 2026). US head Dave Moore says the strategy will help Novo regain ground from $LLY and leverage the strong brand awareness built through Ozempic and Wegovy. Novo is also considering subscription models and will produce the pill in the US to strengthen supply and market presence. This follows news that Novo will"
X Link @investseekers 2025-10-07T07:03Z 4091 followers, 1974 engagements
"Investors are rattled by Trumps comments sending $NVO shares sharply lower says Claus Johansen CEO of Global Health Invest. Trump said Ozempic prices could drop to $XXX a month from around $1000 sparking fears about the ongoing U.S. price negotiations under the Inflation Reduction Act set to conclude Nov. X 2025. The outcome due Nov. XX could be decisive for Novo Nordisk if Ozempic Wegovy and Rybelsus are included. Johansen notes that the sell-off reflects fears of lower Medicare and Medicaid revenue though Trumps suggested cuts imply an even steeper impact. Johansen who holds no Novo shares"
X Link @investseekers 2025-10-17T14:32Z 4108 followers, 2314 engagements
"$BABA s multibillion-dollar AI push is starting to pay off. According to comments from its e-commerce division in October Alibaba has already seen a XX% increase in ad returns after boosting its $53B AI and cloud budget a rare double-digit gain driven by smarter search and virtual try-ons. CEO Wu Yongming calls this a historic investment phase to build an AI-powered e-commerce and cloud platform. Link to article: #StocksToWatch #investing"
X Link @investseekers 2025-10-16T13:33Z 4106 followers, 2008 engagements
"$LLY s oral weight-loss drug Orforglipron was not among the nine new medicines granted priority review by the U.S. FDA despite expectations it might be. It adds to a tough day for Lilly with Trumps renewed criticism of high obesity drug prices also weighing on shares. $C wasnt surprised by the omission while $JPM 's Chris Schott noted another FDA update is expected in the coming months and said we wouldnt be surprised to see Orforglipron included then. #StocksToWatch #investing"
X Link @investseekers 2025-10-17T15:10Z 4108 followers, 1517 engagements
"Watsco ( $WSO ) There are over XXX million HVAC units in service across the US and the installed base grows every year. Most of Watscos business comes from replacements not new construction. When a system breaks it must be replaced making this one of the most resilient industrial markets around. Watscos growth is powered by: A steady replacement cycle (820 years) The shift from gas furnaces to electric heat pumps (more frequent replacements) A strong acquisition track record (70+ deals since 1989) Digital innovation e-commerce now drives $2.6B in sales (35% of revenue) Its tech investments"
X Link @investseekers 2025-10-11T10:55Z 4094 followers, XXX engagements
"$NVO is ending its work and research in cell therapy resulting in around XXX layoffs reports Finans a Danish financial news outlet. In an email to the outlet Novo confirmed: We have decided to stop our research and development activities within cell therapy. The decision is part of the large round of layoffs that began in September. The unit had been researching treatments for Parkinsons chronic heart failure and type X diabetes. #stocks #investing"
X Link @investseekers 2025-10-10T18:32Z 4100 followers, 3012 engagements
"@ResearchPulse1 No. It was a report from Market Wire which refers to Morgan Stanley"
X Link @investseekers 2025-10-14T14:04Z 4086 followers, XXX engagements
"Nordea raises its price target on $CHEMM to DKK XXX from DKK XXX maintaining a Buy rating. Probably my favorite Danish small cap. You can read why in my analysis here: #StocksToWatch #investing"
X Link @investseekers 2025-10-17T19:43Z 4108 followers, XXX engagements
"Billionaire investor Chris Hohn founder of TCI Fund Management explains why he bought $AENA at its IPO and still holds it today: Ive always liked infrastructure. Its boring toll roads airports cell towers but you dont lose your capital. When Spain IPOd Aena it was a monopoly of irreplaceable airports sold at a XX% free cash flow yield. Youll never rebuild Madrid or Barcelona airports. Full analysis of Aena: #stocks #investing #Airport"
X Link @investseekers 2025-10-11T19:21Z 4104 followers, 1836 engagements
"$BAC cuts its price target on $ZEAL to DKK XXX from XXX citing intensifying competition in obesity drug development. BofA says $LLY s upcoming phase X data on amylin candidate Eloralintide is the biggest risk setting a new benchmark ahead of Zealand Pharma and Roches Petrelintide readout in H1 2026. #Stocks #investing #obesity"
X Link @investseekers 2025-09-04T09:57Z 4109 followers, XXX engagements
"@Mike_Tradewatch I'm quite confident that demand holds for all three companies. I understand that tariffs can affect $WSO but why wouldn't demand hold for $CPRT"
X Link @investseekers 2025-10-11T13:25Z 4087 followers, XXX engagements
"$NVO is buying $AKRO for $4.7B (plus a potential $0.5B bonus) to expand its pipeline for liver disease treatments. Akeros main drug efruxifermin is the only medicine so far to show it can reverse liver scarring in advanced-stage MASH patients. Its now in phase X trials. Novo believes it could become a key treatment for MASH a serious liver disease linked to obesity and possibly work alongside Wegovy. The deal strengthens Novos position in metabolic diseases and supports its long-term growth strategy. #stocks #investing"
X Link @investseekers 2025-10-09T10:40Z 4091 followers, 7051 engagements
"I just read through $NVO s M&A call transcript about the Akero Therapeutics acquisition and here are my notes Why Novo Nordisk is buying Akero Novo Nordisk is acquiring Akero Therapeutics for about $XXX billion to get its late-stage drug efruxifermin (EFX) which targets MASH a serious liver disease closely linked to obesity and diabetes. More than XX% of MASH patients are overweight or obese so this fits perfectly with Novos focus on metabolic diseases. Around XXX million people suffer from MASH globally and the number is growing fast. Novo already entered the space in August when Wegovy"
X Link @investseekers 2025-10-09T17:32Z 4109 followers, 21.5K engagements
"#DonaldTrump says the price of Ozempic $NVO s diabetes drug will soon be much cheaper in the US. Speaking at a White House event on fertility and drug pricing Trump said negotiations are moving quickly and specifically named Ozempic calling it that weight-loss drug. Novo Nordisk confirmed its in talks with the Trump administration about improving affordability and access but did not comment directly on Trumps remarks. Trump has previously said the monthly cost could drop from $1300 to $XXX. Novo already cut its list price by half in September to $XXX for uninsured patients. Ozempic is also"
X Link @investseekers 2025-10-17T05:33Z 4108 followers, 9109 engagements
"$CPRT is down XX% this year trading at its lowest valuation since 2017. Its still one of the highest-quality businesses in the market but does that make it a buy now I just updated my analysis here: #StocksToWatch #Investing"
X Link @investseekers 2025-10-05T19:31Z 4086 followers, 1410 engagements
"I opened a position in $LSEG.L London Stock Exchange Group is far more than an exchange. XX% of its revenue is high-margin recurring subscriptions from data analytics indices & risk tools. It also owns LCH which clears most of the worlds interest rate swap trades. The stock trades at a discount because Annual Subscription Value growth slowed during the migration from Eikon to Workspace and due to competitor discounting. Management says these are short-term issues pointing out they have seen rivals cut prices before it wasnt sustainable then and wont be now. Today LSEG trades at its highest"
X Link @investseekers 2025-09-19T14:45Z 4100 followers, 1729 engagements
"@inversionmedica Im just summarizing the article. Personally I dont consider $NVO speculative it is my second-largest position"
X Link @investseekers 2025-10-12T18:20Z 4094 followers, XXX engagements
"The Novo Nordisk Foundation the main owner of $NVO through Novo Holdings is funding a major new global health initiative the Global Pathogen Analysis Platform (GPAP) with up to DKK XXX million to strengthen pandemic preparedness worldwide. Based at DTU with partners at University of Copenhagen Statens Serum Institut and Imperial College London GPAP will use AI-powered genomic analysis to detect and track infectious diseases and will be free to use globally. Fragmented surveillance has left the world vulnerable said Lene Oddershede from the Novo Nordisk Foundation. GPAP will provide a secure"
X Link @investseekers 2025-10-13T07:15Z 4105 followers, 2028 engagements
"Algeria and $NVO have signed a strategic deal to boost local insulin production in partnership with state-owned pharma group Saidal. The agreement aims to enhance pharmaceutical sovereignty reduce imports and improve access for Algerias 4M diabetes patients 1.5M of whom depend on insulin. Novo Nordisk will transfer technology and expertise to Saidal to establish a world-class aseptic production facility ensuring international quality standards and long-term healthcare resilience. #StocksToWatch #investing"
X Link @investseekers 2025-10-17T06:31Z 4108 followers, 1846 engagements
"@unusual_whales Warren Buffett emphasizes that integrity is the most critical quality in management believing that a lack of it is disastrous even in intelligent and energetic individuals. I don't think I could ever invest in $HIMS"
X Link @investseekers 2025-10-17T16:10Z 4108 followers, 16.6K engagements
"Danske Bank analyst Mads Zink on $NVO s rise after EU label expansion for Rybelsus: The approval was XXX% expected. The stock is up because its a positive in whats been a stretch of negative news. A series of small positives can shift momentum. #StocksToWatch #investing"
X Link @investseekers 2025-09-15T16:45Z 4100 followers, 1351 engagements
"$GMAB s DKK 51B ($7.5B) acquisition of Dutch biotech Merus gives the Danish company access to petosemtamab a late-stage cancer drug with multi-blockbuster potential. Analysts highlight that the deal addresses one of Genmabs biggest challenges: bridging the patent cliff expected from 2030 when revenues from its blockbuster Darzalex begin to fade. Petosemtamab has shown highly promising Phase X results in head and neck cancer where current first-line treatments like Mercks Keytruda or chemotherapy deliver X year average survival. In comparison petosemtamab showed XX% survival after one year."
X Link @investseekers 2025-09-29T12:10Z 4100 followers, 1670 engagements
"These X companies Zoetis Watsco and Copart operate in very different industries but they share one trait: structural long-term growth independent of short-term market noise"
X Link @investseekers 2025-10-11T10:55Z 4086 followers, XXX engagements
"Handelsbanken has lowered its price target for $NVO to DKK XXX from DKK XXX while keeping a buyrating. The bank cut its Ozempic forecast due to weaker U.S. prescription trends and concerns over IRA price negotiations but still expects XX% revenue growth in 2026 driven entirely by Wegovy. #StocksToWatch #investing"
X Link @investseekers 2025-10-16T07:50Z 4108 followers, 1866 engagements
"$NVO launching Wegovy in Argentina now approved for both adults and teens (12+)"
X Link @investseekers 2025-10-14T18:06Z 4086 followers, XXX engagements
"@baselineX2024 No I havent. But I know that $LLY has increased prices which should mean $NVO could gain market share. I tweeted about it some time ago but I havent seen any specific news over the weekend. What is the news"
X Link @investseekers 2025-10-12T17:04Z 4094 followers, XXX engagements
"@sudokhanh @unusual_whales My portfolio is public. You can read more about where to see it here:"
X Link @investseekers 2025-10-17T18:49Z 4108 followers, XXX engagements
"$NVO has faced a tough few months with layoffs policy uncertainty and pressure on its U.S. growth outlook. But according to a new report from JPMorgan the long-term picture still looks promising. $JPM now expects Novo to see low to mid single-digit growth (around 34%) in 2026 and 2027 as pricing headwinds from the Trump administrations Most Favoured Nation policy and upcoming Medicare negotiations temporarily weigh on results. The bank expects the company to lower U.S. prices for Ozempic and Wegovy in line with international levels. However from 2028 onward growth is expected to reaccelerate"
X Link @investseekers 2025-10-09T12:32Z 4109 followers, 2790 engagements
"$DB says Novo Nordisks Wegovy pill could play a key role in both diabetes & obesity. After EASD data from $NVO & $LLY analyst Emmanuel Papadakis notes oral semaglutide will have a role in both markets. Deutsche Bank keeps a Buy rating on Novo with a DKK XXX PT. #stocks #investing"
X Link @investseekers 2025-09-18T10:27Z 4097 followers, 1657 engagements
"Per Hansen investment economist at Nordnet notes that when Donald Trump says jump investors still do sometimes even on old news. After Trump repeated Thursday that the price of Ozempic will soon be much cheaper in the U.S. $NVO s ADRs fell X% post-market. Trump just repeated his old line weight-loss drug prices will come down. Investors react again even though theres nothing new says Hansen. Ozempic/Wegovy has been part of Medicare price negotiations since January with results expected in the coming months and taking effect from 2027. Hansen adds that this is a non-news reaction prices are"
X Link @investseekers 2025-10-17T07:29Z 4108 followers, 6207 engagements
"The Danish C25 index closed down XXX% on Tuesday as several healthcare stocks came under pressure. $NVO was the biggest loser of the day falling XXX% with most of the decline coming after U.S. trading began. #stocks #Investing #Denmark"
X Link @investseekers 2025-10-07T16:18Z 4100 followers, XXX engagements
"$NVO and $LLY could be heading for the next big battle not in diabetes but Alzheimers. Novos Rybelsus may protect brain blood vessels and slow Alzheimers progression while Lillys cheaper oral GLP-1 drug orforglipron could make the approach viable at scale. The race for the first Alzheimers pill is heating up. Full article: #stocks #Investing"
X Link @investseekers 2025-10-07T05:10Z 4097 followers, 5703 engagements
"Copart ( $CPRT ) Coparts business runs on auction liquidity the more bidders per car the higher the sale price. That flywheel is powerful: More buyers higher prices more sellers even more buyers. Coparts average selling prices rose XXX% in FY25 beating broader used-car indices. Beyond insurance vehicles Copart is growing with rental fleets banks and dealers which diversifies supply and strengthens the platform. Rising repair costs (especially with EVs) mean more totaled cars fueling long-term supply. Copart combines network effects scale and capital efficiency in a business that keeps"
X Link @investseekers 2025-10-11T10:55Z 4086 followers, XXX engagements
"$NVO s oral obesity drug Monlunabant (INV-202) showed promising Phase 2a results published in The Lancet Diabetes & Endocrinology. In a 16-week trial with XXX adults patients lost X kg vs XXX kg on placebo with improvements in glucose and lipid levels. Monlunabant works by blocking CB1 receptors outside the brain helping reduce fat storage and improve metabolism while avoiding the mood-related side effects that hurt earlier CB1 drugs. Novo Nordisk plans to test it in larger Phase 2b studies as a potential new oral treatment for obesity and related metabolic disorders. Link to article: #stocks"
X Link @investseekers 2025-10-17T20:31Z 4108 followers, 2978 engagements
"Investors are selling $NVO shares on Monday after renewed pressure on the stock. According to Sydbank several factors are weighing on the Danish drugmaker. SEB cut its price target from DKK XXX to XXX citing weaker Ozempic sales in the U.S. and lower growth expectations toward 2026 though it still sees XX% upside over the next XX months. Novo also faces new scrutiny over potential side effects of Wegovy Ozempic and Rybelsus after the EMA added warnings about a rare eye condition (NAION). Adding to the uncertainty recent price-cut deals between Donald Trump and Pfizer/AstraZeneca could"
X Link @investseekers 2025-10-13T11:46Z 4101 followers, 2294 engagements
"The Danish C25 index closed down XXX% today driven by weakness in healthcare stocks. $NVO fell XXX% after U.S. President Donald Trump renewed his focus on drug prices putting pressure on the sector. $ZEAL was the biggest loser of the day down 8.4%. #stocks #investing"
X Link @investseekers 2025-10-17T17:18Z 4108 followers, XXX engagements
"$JEF says $BABA s growth momentum likely remained strong in the September quarter. Customer management revenue is expected to rise XX% YoY supported by solid traffic growth in on-demand delivery. Cloud growth also likely accelerated driven by strong AI demand and Alibabas full-stack AI infrastructure. Jefferies keeps Alibaba as its top pick for 2026 with a Buy rating and a $XXX target price (vs $XXXXXX last). #stocks #investing"
X Link @investseekers 2025-10-09T10:27Z 4107 followers, 1017 engagements
"The Danish C25 index rose XXX% on Monday. Hearing aid maker GN Store Nord led the gains jumping X% despite no company-specific news. $NVO shares also climbed X% after reports over the weekend that $COST customers in the U.S. will soon be able to buy Ozempic and Wegovy at about half price in stores. #stocks #investing #Denmark"
X Link @investseekers 2025-10-06T15:20Z 4107 followers, 1315 engagements
"$DPZ reports earnings tomorrow. #WarrenBuffett has been buying shares recently and for good reason. Its the worlds largest pizza chain built on delivery carryout and an asset-light franchise model that keeps margins strong. My full analysis:"
X Link @investseekers 2025-10-13T19:12Z 4104 followers, 1278 engagements
"A calculation error sent $UPST shares tumbling 11%. BTIG had mistakenly reported that XXXX% of loans were delinquent in August the real figure was 6.2%. The correction came Tuesday night after the stock had already plunged. Danish asset manager Horizon3 sees the drop as a buying opportunity but I personally wouldnt invest in Upstart which I explained in my analysis here: #stocks #investing"
X Link @investseekers 2025-10-06T06:56Z 4086 followers, 1946 engagements
"ChemoMetex ( $CHEMM ) posted strong results in FY 2024/25 despite rising uncertainty. Revenue grew XX% to DKK 496m and EBITDA jumped to DKK 258m from 186m. For FY 2025/26 the company expects revenue of DKK 545565m and EBITDA of DKK 295315m. CEO Martin Helbo Behrens points to rising demand for automation in cell and gene therapy with new XcytoMatic instruments well placed to capture this growth. It remains one of my favourite Danish small caps and I hope to start a position at some point. #stocks #investing"
X Link @investseekers 2025-09-12T05:35Z 4085 followers, 1237 engagements
"$NVO and Sumitomo Pharma have signed a co-promotion deal for Wegovy in Japan starting November 2025. Under the agreement Novo will handle manufacturing and approval while both companies will jointly promote the obesity treatment to healthcare professionals. The partnership builds on their existing collaboration around Ozempic aiming to expand access to obesity care in Japan where an estimated XX million people live with obesity. #stocks #investing #obesity #Japan"
X Link @investseekers 2025-10-15T05:34Z 4108 followers, 5594 engagements
"I bought shares in Constellation Software ( $CSU.TO ) yesterday. Heres why: What it does It buys and runs hundreds of small niche software companies things like traffic light systems library software or church administration tools. These products are essential for their customers so very few ever leave. On average a customer stays for about XX years. Around half of its revenue comes from government clients which makes the cash flow stable and predictable. What makes it different It gives founders a permanent home for their businesses instead of buying and reselling them. The company is"
X Link @investseekers 2025-10-07T10:08Z 4104 followers, 2144 engagements
"$FAST reports earnings tomorrow. It may not sound like the most exciting business with its bolts nuts screws and washers but its surprisingly profitable. Heres why this quiet industrial distributor keeps delivering: #stocks #investing"
X Link @investseekers 2025-10-12T19:18Z 4087 followers, 1065 engagements
"Swiss pharma giant Roche has spent recent years building a portfolio of weight-loss drugs to capture a share of the booming obesity market dominated by $NVO and $LLY. We now have to deliver on that portfolio said Manu Chakravarthy Roches head of metabolic disease in an interview with Finans. Roche has invested around $6.5B in biotech partnerships focused on obesity diabetes and related diseases a figure that could reach $14B as milestones are met. One major deal is with $ZEAL where Roche paid $1.65B upfront (up to $5.3B total) for rights to its promising obesity drug petrelintide. Link to"
X Link @investseekers 2025-10-16T14:26Z 4108 followers, 2005 engagements
"$TEP.PA reports earnings Thursday. Some fear #AI disruption but management sees it as a tailwind. If theyre right the stock seems cheap. Full analysis here: #stocks #investing"
X Link @investseekers 2025-07-30T19:44Z 4105 followers, XXX engagements
"$ZEAL gains Thursday possibly lifted by Novo Nordisks comments on its amylin drug cagrilintide. $NVO said the therapy could serve patients needing moderate weight loss or weight maintenance. Jyske Bank notes this may have boosted sentiment for Zealand which is developing its own amylin drug with Roche. I own a small position in Zealand Pharma"
X Link @investseekers 2025-09-18T13:49Z 4108 followers, 1133 engagements
"$NVO shares are down around X% on the Danish exchange Friday morning following a decline in its U.S. ADRs after hours Thursday. According to Evan David Seigerman from BMO Capital Markets the selloff is overdone. He says GLP-1 drug prices will remain under pressure but Trumps comments only confirm what we already knew. #StocksToWatch #investing"
X Link @investseekers 2025-10-17T08:00Z 4108 followers, 3215 engagements
"@ResearchPulse1 To my knowledge it was approved in 2023. It has been marketed since XX February 2024 in Japan:"
X Link @investseekers 2025-10-15T07:19Z 4104 followers, XXX engagements
"Last week #Prosus repurchased 2285237 $PRX shares at an average price of XXXXX. They have been buying back shares every week since June 2022. #stocks #investing"
X Link @investseekers 2025-08-19T17:33Z 4086 followers, XXX engagements
"Per Hansen investment economist form Nordnet has a great write-up on lower U.S. drug prices and what it could mean for $NVO. In recent weeks $PFE and $AZN have struck deals with Donald Trump to lower U.S. prices in exchange for avoiding import tariffs by moving production to the U.S. within X years. Markets didnt panic both stocks rose after the announcements showing that lower prices arent necessarily bad news for pharma. For Novo Nordisk the situation could be different: it already produces most of what it sells in the U.S. inside the country giving it a potential advantage. Still investors"
X Link @investseekers 2025-10-13T05:43Z 4108 followers, 4144 engagements
"Rothschild & Co Redburn raises its price target on $NVO to DKK XXX from DKK XXX maintaining a Buy rating. #stocks #investing"
X Link @investseekers 2025-10-17T11:41Z 4108 followers, 2251 engagements
"$NVO shares are down XXX% Tuesday afternoon placing the stock at the bottom of Denmarks C25 index. New industry data suggest the company may be losing GLP-1 market share in Europe to rival $LLY according to $MS. The data based on IQVIA figures through August 2025 indicate Lillys gains are driven by product differentiation and commercial execution rather than supply analysts say. Eli Lilly shares are down XXX% premarket in the U.S. but remain up X% YTD while Novo Nordisk has fallen about 40%. #StocksToWatch #investing"
X Link @investseekers 2025-10-14T11:48Z 4109 followers, 6452 engagements
"$NVO just posted a new job opening: Senior Director Medical Affairs Alzheimers Disease based in Copenhagen. The description says they are pushing the boundaries of science with an innovation that could reshape how Alzheimers is understood and treated. Given the timing and wording this could hint that results from the ENVOKE and ENVOKE+ Alzheimers trials might be promising #stocks #investing"
X Link @investseekers 2025-10-17T05:59Z 4108 followers, 10.7K engagements
"$UBS analysts say Trumps comments on cutting $NVO 's Ozempic prices shouldnt surprise investors potential U.S. price reductions are already factored into their forecasts. If the prices mentioned by President Trump end up being the negotiated prices this would already be captured in our numbers they wrote. #StocksToWatch #investing"
X Link @investseekers 2025-10-17T09:45Z 4108 followers, 2587 engagements
"$NVO is entering a difficult phase as the company plans to lay off thousands of employees 5000 in Denmark and 4000 abroad. Experts warn the job cuts could lead to further challenges with up to XX% of remaining staff likely to leave voluntarily due to growing dissatisfaction and uncertainty. New CEO Mike Doustdar now faces the tough task of maintaining morale and retaining key talent amid the restructuring. #stocks #Investing"
X Link @investseekers 2025-10-07T14:52Z 4106 followers, 2385 engagements
"Terry Smiths Fundsmith recently added $INTU and its easy to see why. Its scale data brand and integrated products create strong network effects and high switching costs. I just updated my analysis: #stocks #Investing"
X Link @investseekers 2025-10-07T19:35Z 4097 followers, XXX engagements
"The Danish C25 index closed Friday up 0.77%. Winners: Ambu +6.60% Novonesis +2.79% Pandora +2.54% $NVO +2.19% rsted +1.95% Losers: GN Store Nord -XXXX% Coloplast -XXXX% DSV -XXXX% $GMAB -XXXX% Danske Bank -XXXX% #StocksInFocus #investing"
X Link @investseekers 2025-08-22T15:24Z 4086 followers, XXX engagements
"Want Want #stocks closed down nearly X% today. Its one of Greater Chinas leading food & beverage companies. Best known for its rice crackers milk drinks and snacks loved across generations. Despite the drop the company shows strong fundamentals: Consistent innovation with new products contributing double-digit revenue growth Expanding sales channels through e-commerce and smart vending machines Double-digit overseas growth led by Japan North America & Southeast Asia ROIC above XX% for a decade exceeding XX% in FY2025 A classic example of a steady compounder hiding behind a simple brand. Full"
X Link @investseekers 2025-10-14T09:11Z 4109 followers, XXX engagements
"According to its latest newsletter Danish investment fund MW Compounders has made $NVO its largest position last quarter. The fund writes that despite Novos weak share performance for three consecutive quarters its fundamental value is far above the current price. The manager used the summer dip to increase the position. He notes Novo has faced issues in the US including compounding pharmacies copying its obesity drugs after earlier supply shortages political pressure on drug costs and some pipeline setbacks. Still he expects improving conditions cost-cutting progress under the new CEO and"
X Link @investseekers 2025-10-07T11:13Z 4094 followers, 2612 engagements
"I added to my position in $POOL today. Besides $NVO its the only stock in my portfolio thats still negative. #WarrenBuffett has been buying shares recently and for good reason. You can learn more about the company here: #stocks #investing"
X Link @investseekers 2025-10-09T19:38Z 4086 followers, 1400 engagements
"$NVO is expanding its rare disease portfolio with a new deal to acquire zaltenibart (OMS906) from Omeros a promising treatment for rare blood and kidney disorders. Omeros will get $340M upfront and up to $2.1B in potential milestone payments. Novo plans to start a global phase X trial in paroxysmal nocturnal hemoglobinuria. #stocks #investing"
X Link @investseekers 2025-10-15T12:46Z 4104 followers, 3053 engagements
"$HSBC has upgraded $NVO to Buy from Hold. Analyst Rajesh Kumar says Novos pipeline is undervalued and not weaker than $LLY s especially after strong data from oral semaglutide and orforglipron. Key 2026 catalysts: REDEFINE4 trial testing CagriSema head-to-head vs Lillys Zepbound EVOKE trial testing oral semaglutide in Alzheimers He also highlights Novos stronger focus on reimbursed and direct-to-consumer channels. #stocks #Investing"
X Link @investseekers 2025-10-02T05:04Z 4089 followers, 2129 engagements
"#Prosus repurchased another 1479279 shares last week at an average price of XXXXX. The ongoing buyback program continues by selling #Tencent shares to buy back $PRX shares at a discount increasing the Tencent holding per Prosus share. #stocks #Investing"
X Link @investseekers 2025-10-07T18:20Z 4107 followers, XXX engagements
"The Danish C25 index fell XXX% on Monday. At the bottom were GN Store Nord down XXX% and Vestas down 2.3%. On the positive side $GMAB rose XXX% and A.P. Mller Mrsk gained XXX% while $NVO ended the day down 0.9%. #stocks #investing #Denmark"
X Link @investseekers 2025-10-13T18:41Z 4106 followers, 1293 engagements
"$GMAB announced that global DARZALEX sales reached $XXXX billion in Q3 2025 according to $JNJ. Sales totaled $2.09B in the U.S. and $1.58B internationally. Genmab earns royalties on worldwide DARZALEX sales under its license agreement with J&J. #stocks #investing"
X Link @investseekers 2025-10-14T10:37Z 4100 followers, 1086 engagements
"The Danish C25 index fell XXX% Monday dragged down by rsted closing -16.4%. Winners: Zealand Pharma +1.4% $NVO +0.9% $GMAB +0.3% Sydbank +0.2% Losers: rsted -XXXX% GN Store Nord -XXX% Vestas -XXX% Maersk B -XXX% Pandora -XXX% #Stocks #investing"
X Link @investseekers 2025-08-25T16:22Z 4086 followers, XXX engagements
"CEO of Zealand Pharma did a Q&A on Danish investor site Proinvestor. If youre interested in companies like $NVO or $LLY or just obesity in general its definitely worth a read. Here are my notes: Zealand is stronger than ever: $1.4B upfront payment from Roche unique 50/50 profit split in US & Europe and Roche covers all manufacturing investments. Petrelintide (amylin analog) is the crown jewel. Early data: significant weight loss with fewer GI side effects vs GLP-1s. Could become the foundational therapy for obesity treatment. Phase X results (ZUPREME-1 & 2) due H1 2026. Phase X monotherapy"
X Link @investseekers 2025-08-27T14:44Z 4109 followers, 4034 engagements
"$RMD is the leader in its sector. But as $NVO and $LLY obesity drugs gain more traction will demand for ResMeds products shrink I just updated my analysis: #Stocks #investingtips"
X Link @investseekers 2025-09-06T05:58Z 4104 followers, 1016 engagements
"$DIA.MI is trading near a 52-week low and at its highest free cash flow yield in a decade. In case you don't know DiaSorin: it is a focused diagnostics company based in Italy that develops both lab instruments and test kits used to diagnose a wide range of medical conditions. The company specializes in in vitro diagnostics meaning tests performed in laboratories on blood tissue and other biological samples. It concentrates on areas such as infectious diseases hormone disorders autoimmune conditions and oncology. This specialized focus has enabled DiaSorin to build deep scientific expertise"
X Link @investseekers 2025-07-04T12:45Z 4107 followers, XXX engagements
"Jyske Bank says $NVO s $4.7B acquisition of $AKRO its largest R&D deal ever strengthens its pipeline in MASH a severe liver disease with no approved treatments. While the market initially reacted negatively due to uncertainty around MASH and higher near-term R&D costs Jyske Bank calls the deal overall positive. Novo gains rights to Efruxifermin seen as a potential first- and best-in-class treatment for advanced (F4) MASH possibly used alone or with Wegovy which already targets earlier MASH stages. With an estimated 250M people globally affected the unmet need is huge. Rival pharma giants"
X Link @investseekers 2025-10-10T07:35Z 4107 followers, 2619 engagements
"$AHT.L reports Wednesday. Best known as Sunbelt Rentals its a market leader in equipment rental and market leaders often compound for decades. My analysis: #Stocks #investing"
X Link @investseekers 2025-09-02T14:16Z 4101 followers, XXX engagements
"$NVO continues to be one of the best opportunities in the market"
X Link @investseekers 2025-10-12T14:30Z 4107 followers, 33.3K engagements
"$OXM reports earnings tonight. It owns Tommy Bahama Lilly Pulitzer & Johnny Was with pricing power loyal customers and strong DTC execution. Yet the stock is down nearly XX% this year. My full analysis here: #stocks #investing"
X Link @investseekers 2025-09-10T19:39Z 4107 followers, XXX engagements
"Its interesting because both the CEO of Zealand Pharma and the CFO of Novo Nordisk have said they expect the vast majority to stick with injections at least until 2030. But that is probably among people with obesity while those looking to lose weight for aesthetic reasons will likely prefer the pill. But youre the expert not me 😀"
X Link @investseekers 2025-10-17T11:40Z 4106 followers, XXX engagements
"Denmarks C25 index rose XXX% Monday led by rsted (+3.5%) after reports Equinor is ready to buy shares worth billions. $NVO gained as new data showed Wegovy outperforms $LLY's Zepbound on cardiovascular risk reduction while Zealand Pharma climbed XXX% and $GMAB XXX% #StocksInFocus #investing"
X Link @investseekers 2025-09-01T15:23Z 4109 followers, 1412 engagements
"$GMAB will get news from the U.S. today as its partner $JNJ reports Q3 earnings. The results will include new sales figures for Darzalex the blockbuster cancer treatment co-developed by Genmab. J&J holds the marketing rights and pays royalties to Genmab. Genmab last raised its 2025 Darzalex sales forecast to $13.714.1 billion. #stocks #investing"
X Link @investseekers 2025-10-14T08:49Z 4108 followers, 1239 engagements
"$TEP.PA dropped over XX% today after unveiling its Future Forward strategy. Investors are uneasy about the near-term costs and payoff timeline. Is it a buying opportunity Read the full analysis here: #StocksInFocus #investing"
X Link @investseekers 2025-06-18T18:20Z 4105 followers, XXX engagements
"Zacks featured $LLY $NVO $AMGN and $VKTX in its latest analyst blog. Eli Lilly reports Q3 earnings on Oct XX and all eyes are on its GLP-1 blockbusters. Analysts estimate Mounjaro sales at $5.3B and Zepbound at $3.5B. $GS expects the U.S. obesity market to reach $100B by 2030. Lilly and Novo Nordisk dominate but Amgen (MariTide) and Viking Therapeutics (VK2735) are emerging challengers. Zacks rates Eli Lilly a Hold strong growth momentum but a premium valuation at XX forward earnings. #StocksToWatch #investing"
X Link @investseekers 2025-10-17T15:47Z 4108 followers, 1336 engagements
"Short interest in major Danish stocks: GN Store Nord: XXX% (most shorted stock in Denmark) $ZEAL: XXX% (shorts declining) Vestas: XXX% Mrsk: XXX% Pandora: XXX% rsted: XXX% Novonesis: XXX% $GMAB: XXX% $NVO: XXX% #stocks #Investing"
X Link @investseekers 2025-10-03T06:47Z 4107 followers, 1864 engagements
"Cathie Woods ARK Invest keeps buying $BABA adding over 4000 shares to its flagship $ARKK ETF last week. That brings ARKKs total exposure to about $XX million as ARK continues its steady accumulation of the Chinese tech giant. #stocks #investing"
X Link @investseekers 2025-10-13T10:12Z 4104 followers, 1256 engagements
"$NVO shares are falling sharply on Friday after U.S. President #DonaldTrump once again demands lower prices for weight-loss drugs. According to Sydbanks senior analyst Sren Lntoft Hansen investors are focusing only on the negatives but potential deals with the Trump administration could also create opportunities. He points to $PFE s agreement to lower prices for Medicaid patients in exchange for three years of tariff exemptions as an example. Trump specifically mentions Ozempic which shares the same active ingredient as Wegovy saying prices will be much lower. Novo is already in price"
X Link @investseekers 2025-10-17T13:02Z 4108 followers, 2946 engagements
"Health investor Claus Henrik Johansen (CEO Global Health Invest) calls $GMAB s $8B acquisition of Merus 'extremely positive.' He says the $8B is well spent and strengthens the long-term case giving Genmab a new pipeline to build on toward the end of this decade and into the next. Cancer is a field where acquisitions are a natural way to add products and Merus lead drug could secure Genmab a strong position in head & neck cancer a hard-to-treat disease where even small improvements can be globally significant. If it also proves effective in colorectal cancer the potential is even greater. He"
X Link @investseekers 2025-09-30T17:22Z 4100 followers, 1070 engagements
"$NVO shares are regaining momentum this week after positive newsflow from the EASD diabetes congress. New real-world data showed Ozempic reduced the risk of heart attack stroke & death by XX% vs $LLY s Trulicity. That helped boost sentiment which Jyske Bank analyst Henrik Hallengreen Laustsen says seems to be slowly turning after a difficult year with too many negative surprises. Deutsche Bank added that Wegovy in pill form is still expected to play an important role across both diabetes & obesity. Berenberg also upgraded Novo to Buy this week. Danske Bank analyst Lars Skovgaard Andersen"
X Link @investseekers 2025-09-18T12:12Z 4108 followers, 1622 engagements
"The Danish C25 index closed slightly higher on Friday ending the week up 0.4%. Jyske Banks late earnings upgrade on Thursday sparked a rally among Danish banks which dominated the top of the index while $NVO ended the day down 0.75%. #stocks #investing #Denmark"
X Link @investseekers 2025-10-10T17:30Z 4109 followers, 1210 engagements
"$RI.PA is down XX% from 2023 highs as health trends GLP-1 drugs & new rivals weigh on alcohol stocks. #WarrenBuffett is buying into the sector. I just updated my analysis: #stocks #investing #alcohol"
X Link @investseekers 2025-09-14T19:26Z 4097 followers, 1681 engagements
"$RBREW reports earnings Tuesday. The Nordic & Baltic beverage leader has built its strength on local brands + partnerships with $PEP & Heineken. Read my full analysis here: #Stocks #investing"
X Link @investseekers 2025-08-25T15:22Z 4086 followers, XXX engagements